Form DEF 14A - Other definitive proxy statements

Share Name	Share Symbol	Market	Type
Edgewell Personal Care Company	NYSE:EPC	NYSE	Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.2895	-0.84%	34.1205	34.68	33.9356	34.10	1,517,199	01:00:00

TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐

Preliminary Proxy Statement

☐

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒

Definitive Proxy Statement

☐

Definitive Additional Materials

☐

Soliciting Material under §240.14a-12

EDGEWELL PERSONAL CARE COMPANY

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒

No fee required.

☐

Fee paid previously with preliminary materials.

☐

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

TABLE OF CONTENTS

TABLE OF CONTENTS

HELP US IN ONE SMALL WAY TO PROTECT THE ENVIRONMENT

ELECTRONIC DELIVERY OF PROXY MATERIALS

At Edgewell, we believe in operating our business responsibly and view our sustainability efforts as an enabler of our growth strategy. Our Sustainable Care 2030 strategy continues to guide us forward as we pursue our ambitious goals and explore new ways to create a positive impact, such as taking action to help conserve natural resources.

To express our appreciation and compound your positive impact, Edgewell is partnering with the Arbor Day Foundation to plant a tree in a forest of need for everyone who switches to digital delivery of their documents.

Choosing to go paperless means less paper waste in the environment, helping fulfill our commitment to protect the planet we all share.

Please follow the instructions to vote your shares and, when prompted, indicate that you agree to receive or access proxy materials electronically for future years. Have your control number available.

[MISSING IMAGE: pg_environmentimpact-4c.jpg]

TABLE OF CONTENTS

Letter to our Shareholders
from our President and Chief Executive Officer
and our Non-Executive Chairman of the Board

December 19, 2024

Dear Fellow Shareholders,

You are cordially invited to attend the Annual Meeting of Shareholders of Edgewell Personal Care Company to be held on February 6, 2025 at 8:30 a.m. Eastern Time at the Renaissance Daytona Beach Oceanfront Hotel, 640 North Atlantic Avenue, Daytona Beach, Florida.

Fiscal 2024 Accomplishments

As we exit the year, and at a macro level, the external environment in which we are operating is mixed. The consumer remains cautious, and in the U.S., consumption across our categories slowed through the year. Inflation, though moderating, remains, and the currency environment continues to be volatile.

Despite these factors, and in a year where top-line growth was below our expectations, our broader strategies continue to yield good results and the strength of our business model remains clear.

Our results in fiscal 2024 further demonstrate the progress we are making in transforming our business, and the effectiveness of the strategy and business model we launched just under four years ago.

Strengthening our Executive Leadership Team

While we remain on track to deliver on our goal of transforming Edgewell into a growing, sustainable, and consumer-centric personal care company, we understand that our journey is still ongoing. In 2024, we continued to refine our leadership team and organization, bringing in a new President of North America, Jessica Spence, and promoting Dan Sullivan to Chief Operating Officer and Francesca Weissman to Chief Financial Officer.

Jessica is a seasoned and accomplished leader with an impressive brand-building and operational background, balanced with a strong track record of driving revenue and profit growth. We are confident that she will strengthen our North America business and position us as a key innovator, partner, and disruptor within the industry. Jessica’s expertise and results-based approach aligns perfectly with Edgewell’s goals of operating with agility and becoming even more consumer-centric, all while continuing to deliver on commercial execution as we move towards the future.

Dan has been with Edgewell since 2019, first as Chief Financial Officer and most recently combining that role with the role of President of Europe and Latin America. Dan’s appointment will streamline and strengthen the Company’s leadership structure, narrow spans of control, enhance the speed of decision-making and improve enterprise execution against critical business priorities to maximize performance.

As part of Dan’s expanded role, we announced in August 2024 that we would be streamlining all our international markets under Dan’s leadership. International now makes up to 44% of our business, so this leadership change effectively simplifies our operating structure to allow for greater focus on commercial innovation and operational execution and better position Edgewell for sustainable top- and bottom-line growth. Our local leadership teams have a broader voice in innovation, and investment and are now executing on the strategies that they have developed.

TABLE OF CONTENTS

Francesca assumed her role as Chief Financial Officer on December 1, formerly serving as the Senior Vice President of Finance and Business Strategy. She will report to Dan and continue to lead all aspects of corporate FP&A and commercial and operational finance. Her additional responsibilities as CFO will include oversight of Controllership and Accounting, Investor Relations, Internal Audit, Tax and Treasury.

We are confident these changes will better position us to deliver on our overarching strategy to drive sustainable top- and bottom-line growth.

Board Leadership and Refreshment

Our Board plays a key role in helping Edgewell execute our strategic plan, manage risk, and create shareholder value. We believe our Board has the right mix of backgrounds, skills, and experiences to do this while representing the diverse interests of our stakeholders — consumers, customers, employees, shareholders, and the communities where our employees work and live.

We also understand that a strong Board must anticipate the needs and demands of the future, and we remain committed to a Board that provides diverse perspectives and broad backgrounds. In September, we welcomed Stephanie Stahl to the Board. As a consumer-driven and sustainability-focused business leader, brand builder, board member and advisor, Stephanie has extensive marketing and strategy experience in high-growth, turnaround, and early-stage operating environments. We believe Stephanie’s consumer goods background is particularly relevant as we continue to execute our near- and long-term strategic priorities. We would also like to recognize Joe O’Leary and thank him for his years of service and the contributions he has made to the Company, and we wish him the best in the future.

Looking Ahead

Overall, we exit fiscal 2024 a stronger, more capable business, one that is better equipped to continue to get closer to our consumers and to build brands people love.

Our outlook for 2025 is underpinned by five overarching priorities:

Strengthen our Right to Play categories in the U.S. to better compete for the long term;

Fortify and accelerate our consumer-centric innovation platform;

Strengthen and leverage growth across our International business;

Improve service levels and our broader execution across the business as we continue on our path to becoming a world class supply chain organization and ultimately, a preferred partner to retailers; and

Strengthen critical, underlying commercial capabilities across the enterprise to drive continued organic top-line growth.

While the external environment remains extremely challenging, and while there is always more to do, the fundamental improvements we’ve made across our business are delivering the expected results and give us confidence that the strategic priorities and choices we’ve made are driving the desired outcomes.

We encourage you to review this Proxy Statement to learn more about the Board, our governance practices, compensation programs and philosophy, and other important developments and priorities at Edgewell. Your vote at the Annual Meeting is important. Whether or not you plan to attend the meeting, we urge you to vote as soon as possible. There are several ways to vote prior to the Annual Meeting. You can vote online or by phone by following the instructions on the enclosed proxy, or you can complete, sign, date and return the enclosed proxy in the envelope provided.

We would like to thank you for your continued interest and investment in Edgewell and for your ongoing engagement with our Company.


	John C. Hunter Non-Executive Chairman of the Board of Directors			Rod R. Little President and Chief Executive Officer

TABLE OF CONTENTS

EDGEWELL PERSONAL CARE COMPANY
6 Research Drive
Shelton, Connecticut 06484

NOTICE OF THE ANNUAL MEETING OF SHAREHOLDERS

The 2025 Annual Meeting of Shareholders of Edgewell Personal Care Company (the “Annual Meeting”) will be held at 8:30 a.m. Eastern Time on Thursday, February 6, 2025 at the Renaissance Daytona Beach Oceanfront Hotel, 640 North Atlantic Avenue, Daytona Beach, Florida.

The purpose of the meeting is:

Election of 10 directors to serve until the 2026 Annual Meeting of Shareholders

FOR

Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2025

FOR

Non-binding advisory vote on executive compensation paid to our named executive officers

FOR

Important Notice Regarding the Internet Availability of Proxy Materials for the Annual Meeting. We are mailing to many of our shareholders a notice of availability over the Internet of the proxy materials, rather than mailing the proxy materials. The notice of availability contains instructions on how to access our proxy materials on the Internet, as well as instructions on obtaining a paper copy. This process will reduce our costs to print and distribute our proxy materials. All shareholders who do not receive such a notice of availability, and any shareholders who request to receive a paper copy of the proxy materials, will receive a full set of paper proxy materials by U.S. mail.

How to Cast Your Vote. You may vote if you were a shareholder of record on November 29, 2024. It is important that your shares be represented and voted at the Annual Meeting. Please vote in one of the following ways:

Internet

Phone
1-800-690-6903

Mail

In Person

www.proxyvote.com using the control number indicated on the notice of availability or proxy card mailed to you

Deadline for voting by phone is 11:59 p.m. (ET) on February 5, 2025

Mark, sign, date and promptly return the proxy card in the postage-paid envelope

Vote by written ballot at the Annual Meeting

This Notice, the Proxy Statement, and our 2024 Annual Report on Form 10-K have also been posted at www.proxyvote.com.

By Order of the Board of Directors,

LaTanya Langley
Chief People Officer & Chief Legal Officer
and Corporate Secretary

December 19, 2024

TABLE OF CONTENTS

Awards

						FORBES AMERICA’S BEST MIDSIZE EMPLOYERS Edgewell was ranked #2 out of 400 companies on Forbes’ list of America’s Best Midsize Employers for 2024 — our first time being listed and a testament to our commitment to being a people first employer.
						FAST COMPANY’S WORLD CHANGING IDEAS Edgewell’s Banana Boat brand was recognized by Fast Company as a Nature Finalist in their World Changing Ideas category for its “Nest Domes” project aimed at supporting sea turtle conservation. The award highlights creative projects across a variety of topics that are helping to shape the world, including innovative sustainability initiatives. Research shows that 99% of sea turtles have been born female as a result of rising sand temperatures. Banana Boat’s LATAM team partnered with The Colombian Sea Turtle Conservation Program and VML to create natural domes aimed at regulating sand temperatures on beaches in order to create ideal conditions in the hopes of achieving an even proportion of female and male newborn sea turtle hatchlings.
						USA TODAY’S AMERICA’S CLIMATE LEADERS Edgewell has been recognized as one of the Climate Leaders in America, the second time USA Today has published its ranking of American companies that achieved the greatest reduction in core emissions intensity. The selection, which was based on a company’s progress in reducing their Scope 1 and 2 greenhouse gas emission intensity, recognizes Edgewell’s work toward being a part of a world in which caring for ourselves is balanced with caring for our shared planet and society.
						NEWSWEEK’S AMERICA’S GREATEST WORKPLACES FOR DIVERSITY Newsweek and market data research firm, Plant-A, have recognized Edgewell as one of the greatest workplaces for diversity. This recognition is a testament to our commitment to building and sustaining an inclusive workplace where every individual feels respected, valued, and supported, regardless of gender, race, or any other characteristic. Edgewell continues to prioritize our teammates and nurture a culture of openness and trust.
						U.S. EPA 2024 SMARTWAY® EXCELLENCE AWARD Edgewell has received the SmartWay® Excellence Award from the U.S. Environmental Protection Agency, as a true industry leader in freight and supply chain environmental performance and energy efficiency. Edgewell was one of 18 shipper companies to receive this distinction, representing the best environmental performers of SmartWay’s more than 4,000 partners. Edgewell has earned this recognition through its deliberate efforts to better optimize and manage distribution. Additionally, Edgewell works to maximize truckloads and consolidate shipments in order to reduce the number of trucks going to any one customer — thereby making fewer, fuller journeys and reducing the total freight miles traveled.

TABLE OF CONTENTS

Fiscal 2024 Performance Highlights

						Returned approximately $90 million to shareholders in the form of $59 million in share repurchases and $31 million of dividends in the full fiscal year.
						Our Right to Win portfolio grew by about 5%, fueled by 7% growth in global Sun Care, while our Grooming brands grew almost 6% for the year.
						From a geographic perspective, our international markets grew by over 7% and now make up about 44% of our total business, and our Right to Win portfolio in North America grew over 3%, with our leading Sun Care and Grooming portfolios both growing mid-single digits.
						Recognized as one of America’s Most Responsible Companies by Newsweek and Statista for the 5th year running. In 2024, we rose to #19 overall — and #3 in our industry. Recognized by USA Today and Statista among their list of America’s Climate Leaders in 2024. Recipient of the Environmental Protection Agency’s SmartWay Excellence Award as a true industry leader in freight and supply chain environmental performance and energy efficiency, one of only 18 shipper companies to receive the award in 2024. Ranked #2 out of 400 companies listed on Forbes’ America’s Best Midsize Employers in 2024 — our first time being listed and a testament to our commitment to being a people-first employer. HR Best Practice Pioneer in South China by The American Chamber of Commerce’s Multinational HR Management Association. Named as one of America’s Best Employers for Women by Forbes Magazine. Named by Newsweek and Plant-A Insights Group’s list of America’s Greatest Workplaces for Diversity as well as their America’s Greatest Workplaces for Women. Named one of the UK’s Best Workplaces in Manufacturing, Production & Transportation by Great Places to Work®.
						The Billie brand continued to win in Women’s Shave, gaining 260 basis points of share as it entered select women’s grooming categories with Walmart, while continuing its journey towards becoming what we believe will be the pre-eminent women’s lifestyle brand.
						Sun and Skin Care net sales for fiscal 2024 were $740.8 million, an increase of $35.3 million, or 5%. Organic net sales increased $32.8 million, or 4.6%, driven by Sun Care growth of 9.1% in international markets and 6.1% in North America, as well as 5.5% growth in global Grooming.

TABLE OF CONTENTS

Our Purpose and Values

Make useful things joyful — this is our purpose, our north star that guides everything we do. We infuse joy into our daily interactions, and we create products that are functional and bring happiness to people. Our values are core to our purpose and inspire our collaborations with teammates, our partnerships with customers, and our connection to consumers. As we innovate for the future, these values are the beacon that keep us on course. They aren’t just words on a page, we live them. They define our expectations — of our products, our company, and ourselves.

TABLE OF CONTENTS

	Page
PROXY STATEMENT SUMMARY
BOARD OF DIRECTORS		1
Snapshot of Your Board Nominees		1
Key Skills and Experience		2
Board & Committee Self-Evaluation		2
Key Skills Details		3
Director Biographies		4
CORPORATE GOVERNANCE
Standing Committees and Meetings		9
Corporate Governance, Risk Oversight, Sustainability and Director Independence		13
Non-Employee Director Compensation for Fiscal 2024		18
A CLEAR PATH FOR SUSTAINABLE GROWTH		20
AUDIT COMMITTEE REPORT		22
EXECUTIVE COMPENSATION		23
NEO Snapshot		24
Fiscal 2024 Performance Highlights		24
Principles of the Edgewell Compensation Program		25
Compensation Policies and Governance Practices		27
Compensation Benchmarking		28
Results of 2024 Advisory Vote to Approve Executive Compensation		29
Summary and Key Elements of Executive Compensation in Fiscal 2024		29
Executive Officer Stock Ownership Requirements		36
Anti-Hedging Policy		36
Incentive Compensation Recoupment Policy		36
Executive Compensation Tables		38
HUMAN CAPITAL & COMPENSATION COMMITTEE REPORT		48
Potential Payments Upon Termination or Change in Control		49
Death, Permanent Disability or Termination of Employment		49
Executive Severance Plan		50
Change in Control of the Company		51
Chief Executive Officer Pay Ratio Disclosure		53

TABLE OF CONTENTS

	Page
Equity Compensation Plan Information		54
Pay versus Performance		55
Stock Ownership Information		58
Five Percent Owners of Common Stock		58
Ownership by Directors and Executive Officers		59
PROPOSALS
Item 1. Election of Directors		63
Item 2. Ratification of Appointment of the Independent Auditor		65
Item 3. Advisory Vote on Executive Compensation		69
PROXY STATEMENT — VOTING PROCEDURES & MEETING FAQs		70
ADDITIONAL INFORMATION		72
Certain Relationships and Related Transactions		72
Other Business		72
Delivery of Documents		73
Shareholder Proposals for 2026 Annual Meeting		73
Appendix A: Reconciliation of Non-GAPP Financial Measures		A-1

Forward-Looking Statements

Certain statements in this proxy statement, including estimates, projections, objectives and expected results and including statements relating to our environmental sustainability, equality and inclusion, and other ESG targets, estimates, projections, goals, commitments, and expected results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are generally identified by the words “believe,” “expect,” “anticipate,” “intend,” “opportunity,” “plan,” “project,” “will,” “should,” “could,” “would,” “likely” and similar expressions. Forward-looking statements are based on current assumptions that are subject to risks and uncertainties that may cause actual results to differ materially from the forward-looking statements, including the risks and uncertainties discussed in Item 1A — Risk Factors of the Form 10-K included in our 2024 Annual Report. Such forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise publicly any forward-looking statements, except as required by law.

Non-Incorporation of Other Materials

Information on the Company’s website, reports or social media feeds is not part of or incorporated by reference in this proxy statement. This proxy statement may identify additional resources that can be found on the Company’s websites. These additional resources, reports, disclosures, and policies are not part of or incorporated by reference in this proxy statement.

TABLE OF CONTENTS

GLOSSARY OF TERMS

Commonly Used Terms in this Proxy Statement

	ASC			Accounting Standards Codification
	Board			Edgewell’s Board of Directors
	CEO			Chief Executive Officer
	CFO			Chief Financial Officer
	CIC			Change in Control Plan
	CPG			Consumer Packaged Goods
	EBITDA			Earnings Before Interest, Taxes, Depreciation and Amortization
	EPS			Earnings Per Share
	ESIP			Executive Savings Investment Plan
	FASB			Financial Accounting Standards Board
	FY			Fiscal Year
	HC&CC			Human Capital & Compensation Committee
	NEO			Named Executive Officer
	NYSE			New York Stock Exchange
	PRSE			Performance Restricted Stock Equivalents
	PwC			PricewaterhouseCoopers LLP
	RSE			Restricted Stock Equivalents
	SEC			Securities and Exchange Commission
	SERP			Supplemental Executive Retirement Plan

TABLE OF CONTENTS

PROXY STATEMENT SUMMARY

This proxy statement (the “Proxy Statement”) and accompanying proxy materials are being furnished to the shareholders of Edgewell Personal Care Company, a Missouri corporation (the “Company” or “Edgewell”), in connection with the solicitation of proxies by the Board of the Company for use at the 2025 Annual Meeting of Shareholders, and at any adjournment or postponement thereof (the “Annual Meeting”), for the purposes set forth in the Notice of the Annual Meeting of Shareholders. This summary highlights information contained elsewhere in this Proxy Statement and in the Company’s Annual Report on Form 10-K for the year ended September 30, 2024. For more complete information about these topics, please review the Company’s complete Proxy Statement and Annual Report on Form 10-K. Please also see the Proxy Statement — Voting Procedures & Meeting FAQs section for important information about proxy materials, voting, and attendance at the Annual Meeting. This summary does not contain all of the information that you should consider, and you should read the entire Proxy Statement carefully before voting.

2025 Annual Meeting

	Time and Date			8:30 a.m. Eastern Time on Thursday, February 6, 2025
	Place			Renaissance Daytona Beach Oceanfront Hotel 640 North Atlantic Avenue Daytona Beach, Florida
	Record Date			November 29, 2024
	For additional information regarding the Annual Meeting, please refer to the section titled “Proxy Statement — Voting Procedures & Meeting FAQs.”

Business of the Meeting

Board
Recommendation

Election of 10 directors to serve until the 2026 Annual Meeting of Shareholders

•

The director nominees have a diverse set of backgrounds, characteristics and skills relevant to the leadership of the Board and oversight of the Company.

•

All of our non-employee directors are independent.

FOR

Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2025

•

Independent firm.

•

Significant industry, global audit and financial reporting expertise.

FOR

Non-binding advisory vote on executive compensation paid to our named executive officers

•

Strong alignment of executive pay with Company performance.

•

Oversight of compensation program by fully independent HC&CC with assistance of independent compensation consultant.

FOR

TABLE OF CONTENTS

BOARD OF DIRECTORS AND CORPORATE GOVERNANCE

Director Nominees (standing for election for a term expiring in 2026)

Name	Age	Professional Background	Board Committees
Robert W. Black	65	Executive Advisor Partner, Wind Point Partners and Chair, RTIC Outdoors	Audit, HC&CC
George R. Corbin	60	Venture Partner, NextGen Venture Partners	Audit, HC&CC
Carla C. Hendra	68	Former Global Chief Executive Officer, Ogilvy Consulting	Corporate Governance, HC&CC
John C. Hunter, III	77	Former Chair, President and Chief Executive Officer, Solutia, Inc.	Non-Executive Chairman of the Board, Audit
James C. Johnson	72	Former General Counsel, Loop Capital Markets LLC	Corporate Governance (Chair), HC&CC
Rod R. Little	55	President and Chief Executive Officer, Edgewell Personal Care Company
Rakesh Sachdev	68	Former Chief Executive Officer, Platform Specialty Products Corporation and Sigma Aldrich Corporation	Corporate Governance, HC&CC (Chair)
Swan Sit	47	Sole Owner, Swan Sit, LLC	Corporate Governance, HC&CC
Stephanie Stahl	57	Senior Advisor, Boston Consulting Group	Audit, HC&CC
Gary K. Waring	65	Former Assurance Partner, Ernst & Young LLP	Audit (Chair), Corporate Governance

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Key Skills and Experience

Experience and Skills

Black

Corbin

Hendra

Hunter

Johnson

Little

Sachdev

Sit

Stahl

Waring

Leadership

Extensive Industry Knowledge

International Perspective

Operations

Digital Commerce

Strategy

Financial

Marketing

Risk/Corporate
Governance/Cybersecurity

Demographics

Independence

Tenure

Gender

Racially or Ethnically Diverse

Board and Committee Self-Evaluation

Our Board believes that a self-evaluation process is important to its ongoing effectiveness. The following describes the process by which our Board carried out these self-evaluations over the past year:

		Annual Board, Committee and Peer Self-Evaluation				The self-evaluation process seeks individual director feedback on the Board and respective committee’s roles and oversight responsibility, structure, relationship with management, meeting agendas, oversight of strategy and risk, and other related topics. Our Board self-assessment also includes an additional opportunity for directors to provide specific feedback on their peers in the form of narrative disclosure to facilitate director performance. Our Corporate Governance Committee oversees the content and process of the self- and peer-evaluations.
		Discussion of Results				Our Non-Executive Chairman of the Board and the Chairs of each committee present the results of the self-evaluation to our Board and their respective committees.
		Incorporation of Feedback				Our Board and committees assess progress in the areas targeted for improvement from the prior evaluation and develop action plans aimed at enhancing our Boards’ and committees’ effectiveness over the next year. Items requiring follow-up are monitored on an ongoing basis by our Board and committees.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Key Skills Details

				LEADERSHIP Executive leaders have an understanding of organizations and the drivers of individual and team growth and development. Directors with experience serving as a CEO or senior executive enhance the Board’s perspective of our organization’s operations and challenges. They understand strategy, productivity, and risk management, and how these factors impact the Company’s operations and controls. Further, their own significant leadership skills and experiences enable them to help identify and develop other successful leaders.
				EXTENSIVE INDUSTRY KNOWLEDGE The categories in which we operate are largely mature and highly competitive, both in the U.S. and globally, as a number of companies compete for consumer acceptance, limited retail shelf space and e-commerce opportunities. Directors with experience serving consumers, brand perceptions, and product performance and innovation, provide valuable insights to the Company. Based on their experience and tenure on our Board, our directors provide us with a better understanding of the challenges and opportunities facing our business.
				INTERNATIONAL PERSPECTIVE We are a global company with a footprint in over 20 countries and our products are widely available in more than 50 countries. The quality of our Board’s oversight and strategic guidance is enhanced by directors whose understanding of diverse business environments, economic conditions and cultures has been informed by service as a director or senior leader at one or more companies with international operations. Our directors bring valuable knowledge to the Company, including exposure to different cultural perspectives and practices, and provide critical insight in light of the Company’s global scope and significant international revenues.
				OPERATIONS Directors with “hands-on” experience developing and implementing operating plans and business strategies at companies with similarly sophisticated business operations have a practical understanding of how such organizations operate in increasingly sophisticated and disruptive competitive environments. Our directors provide valuable insight and leadership into distribution, e-commerce, logistics, innovation, marketing, and sales for a global organization.
				DIGITAL COMMERCE Our directors have significant knowledge of how to anticipate technological trends, generate disruptive innovation, and extend or create new business models. Further, our directors provide oversight into the selection and implementation of new technologies to leverage competitive strengths and give valuable insights related to the digital commerce sector that are relevant to our evolving strategy, business, and operations.
				STRATEGY Because of the highly competitive environment in which we operate, our directors play a pivotal role in strategy, productivity, and risk management. Moreover, as we continue to identify and complete strategic acquisitions and effectively integrate acquired companies, directors with experience leading business value creation through acquisitions, divestitures, and other business transactions are invaluable.
				FINANCIAL The Company’s business is multifaceted and involves complex financial transactions in many countries and in many currencies. Directors with an understanding of accounting and financial reporting processes, particularly in large, global businesses, provide important oversight of our financial statements and strategy and financial reporting to investors and other stakeholders. Directors with proficiency in finance, capital allocation, and financial reporting processes gained from experience acting as, or actively supervising, a principal financial officer are essential for ensuring effective oversight of the Company’s financial measures and processes.
				MARKETING We depend on the continuing reputation and success of our brands. Directors with experience identifying, developing, and marketing new products, as well as identifying new areas for existing products which can positively impact the Company’s operational results, are crucial to helping the Company understand and anticipate evolving marketing platforms and practices. Our directors oversee our brand strategy (or the brand strategy of its brands), ensuring it aligns with the overall business objectives and values, while providing guidance on brand purpose, positioning, messaging, brand identity, creative platform and in-market communications.
				RISK/CORPORATE GOVERNANCE/CYBER SECURITY As a public company, our accounting, financial reporting and information security functions are subject to a rigorous program of controls and procedures and our Board plays an important role in oversight of our robust audit, enterprise risk management and information security organizations. Directors with experience in these areas are critical to evaluating and providing effective oversight of our consolidated financial statements and financial reporting and our management of the risks inherent in our business operations. Likewise, as a Company deeply committed to our Purpose, Values and Behaviors, directors who are well-informed with respect to today’s dynamic governance and ethics environment are crucial to our success. We believe our directors are suitably qualified to guide our Company through the challenges posed by the dynamic regulatory and geopolitical environments we operate in, guide in the execution of our strategic priorities, and provide effective oversight of management.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

INFORMATION ABOUT NOMINEES FOR DIRECTOR

Please review the following information about the nominees who are all standing for election at this meeting for a term expiring at the 2026 Annual Meeting.

	Director since 2018 Board Committees: • Audit • HC&CC			Robert W. Black Mr. Black brings extensive international business, digital commerce, strategy, operations and innovation experience to our Board. At Kimberly-Clark, he led the portfolio reconstruction, reinvigoration and reorganization of the company’s international businesses. Mr. Black led the transformation of the Steelcase International business through acquisitions, rationalized branding, reconfiguration of the organization and the launch of new products. Mr. Black is the Chair of RTIC Outdoors, a direct-to-consumer retailer of outdoor gear. Mr. Black does not currently serve on any other public company board.
				Current and Previous Experience • Wind Point Partners (since 2013) • Executive Advisor Partner • Kimberly-Clark (2006-2012) • Group President • Chief Strategy Officer and Chief Innovation Officer			Past Public Company Boards • LF Capital Acquisition II (2021-2023) • Annie’s, Inc. (2014-2015) Education • BS, Management, State University of New York at Buffalo • MBA, Harvard Business School

	Director since 2018 Board Committees: • Audit • HC&CC			George R. Corbin Mr. Corbin brings extensive disruptive innovation, digital commerce, digital strategy, marketing, business transformation and operations experience to our Board. He has served as Chief Digital Officer and top digital executive for some of the world’s most iconic brands, including Mars, Incorporated where he served in a non-director capacity on the board’s Digital Subcommittee and also as Chief Digital Officer. Prior to Mars, Incorporated, he was Senior Vice President of Digital at Marriott International where he led a $13.5 billion digital business and the company’s global-scale digital transformation. Mr. Corbin serves as a Venture Partner at NextGen Venture Partners. He also served as Chief Operating Officer for travel technology startup, Onriva. Mr. Corbin serves on the Faculty of the National Association of Corporate Directors, where he also holds a Professional Director Certification. Mr. Corbin does not currently serve on any other public company board.
				Current and Previous Experience • NextGen Venture Partners (since 2019) • Venture Partner • Onriva (2021-2023) • Chief Operating Officer • Mars, Incorporated (2017-2019) • Chief Digital Officer • Marriott International (2002-2017) • Senior Vice President, Digital • Vice President, Digital Strategy, Global eMarketing, Global eCommerce Services & International eCommerce • Vice President Digital Strategy			Education • BS, Geology, University of California Davis • MBA, Harvard Business School

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

	Director since 2015 Board Committees: • HC&CC • Corporate Governance			Carla C. Hendra Ms. Hendra brings to our Board extensive experience in marketing, advertising and strategic consulting which gives her insights into commercial issues such as brand strategy, digital marketing, data and analytics, and long-term planning. Ms. Hendra previously served as Global Chief Executive Officer of Ogilvy Consulting, the global strategy consulting and innovation arm of the Ogilvy Group, before her retirement in January 2024. Ms. Hendra does not currently serve on any other public company board.
				Previous Experience • The Ogilvy Group (1996-2024) • Global Chief Executive Officer, Ogilvy Consulting (2011-2024) • Chief Digital Officer, Ogilvy Worldwide (2016-2020) • CEO, Ogilvy North America (2005-2010) • President, OgilvyOne North America (1999-2005)			Past Public Company Boards • Caleres, Inc. (2005-2024) • Nominating & Governance Committee • Technology Committee • Unica (2007-2010) • Governance Committee Education • BA, Humanities, University of Chicago • Textile Design, Fashion Institute of Technology, New York City

	Director since 2005 Non-Executive Chairman since March 2019 Board Committees: • Audit			John C. Hunter, III Mr. Hunter was elected as our Non-Executive Chair of the Board in March 2019. He brings to our Board insightful risk management experience and his extensive experience as a director also provides him with insight into effective compensation plan design and a thorough understanding of current issues, trends and concerns in executive compensation. Mr. Hunter retired from Solutia, Inc. in 2004. During his career with Solutia, he gained many years of experience in the specialty chemicals business and obtained an in-depth knowledge of environmental, regulatory and sustainability issues. Mr. Hunter does not currently serve on any other public company board.
				Previous Experience • Solutia, Inc. (1999-2004) • Chair, President and Chief Executive Officer			Past Public Company Boards • KMG Chemicals, Inc. (2014-2019) • Penford, Inc. (2014-2019) • Hercules/Ashland (2008-2016) Education • BSChE, Georgia Institute of Technology • MBA, University of Houston

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

	Director since 2013 Board Committees: • Corporate Governance, (Chair) • HC&CC			James C. Johnson Mr. Johnson brings extensive executive management and leadership experience to our Board. Prior to serving as General Counsel of Loop Capital Markets LLC, a financial services firm, Mr. Johnson served as Corporate Vice President, Corporate Secretary and Assistant General Counsel of aerospace and defense firms, Northrop Grumman Corporation and The Boeing Company. Mr. Johnson retired as the General Counsel of Loop Capital Markets LLC, a financial services firm, in December 2013. As a former general counsel, Mr. Johnson brings strong legal, compliance, risk management, corporate governance and executive compensation plan design experience to our Board.
				Previous Experience • Loop Capital Markets LLC (2010-2013) • General Counsel			Public Company Boards • Energizer Holdings, Inc. (since 2015) • Governance Committee (Chair) • Ameren Corporation (since 2005) • Compensation Committee • Governance Committee • HanesBrands Inc. (since 2006) • Governance Committee Education • BA & J.D., University of Pennsylvania • Certificate, Cybersecurity Oversight from the NACD

	Director since 2019			Rod R. Little President and Chief Executive Officer, Edgewell Personal Care Company Mr. Little has been our President and Chief Executive Officer since March 2019. From March 2018 to March 2019, Mr. Little served as our Chief Financial Officer. Mr. Little brings more than 20 years of global experience in CPG organizations to our Board, significant public company experience and a strong track record of driving results. As our CFO, he was responsible for the global finance and IT organizations. This combination of experience and deep industry knowledge allow Mr. Little to bring unique insights and perspectives to our Board.
				Previous Experience • HSN, Inc. (2017) • Chief Financial Officer • Elizabeth Arden (2014-2016) • Executive Vice President & Chief Financial Officer • Procter & Gamble (1997-2014) • Various Finance positions			Public Company Boards • Victoria’s Secret & Co. (since 2023) • Human Capital & Compensation Committee Education • BS, Business Management, United States Air Force Academy • MBA, Finance, University of Pittsburgh

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

	Director since 2015 Board Committees: • HC&CC (Chair) • Corporate Governance			Rakesh Sachdev Mr. Sachdev brings experience as both a chief executive officer and a chief financial officer to our Board. As a previous CEO of two public companies, he brings skills and valuable expertise in global management, mergers and acquisitions, and finance. His knowledge of operations, finance, accounting principles and financial reporting rules and regulations, his experience in evaluating financial results and generally overseeing the financial reporting processes of a large public company, provide substantial insights to our Board. Mr. Sachdev acts as an advisor to New Mountain Capital and certain of their portfolio companies. In the past, Mr. Sachdev has served as the Chairman of the Federal Reserve Bank of St. Louis.
				Previous Experience • Platform Specialty Products Corporation (now Element Solutions, Inc.) (2016-2019) • Chief Executive Officer • Sigma-Aldrich Corporation (2008-2015) • President and Chief Executive Officer • Chief Financial Officer and Chief Administrative Officer Past Public Company Boards • Element Solutions, Inc. (2019-2020) • Platform Specialty Products Corporation (2016-2019) • Sigma Aldrich Corporation (2010-2015) • Avantor, Inc. (2019-2021)			Public Company Boards • HERC Holding (since 2021) • Audit Committee • Axalta Coating Systems (since 2020) • Compensation Committee • Governance Committee • Regal Rexnord Corporation (since 2007) • Compensation Committee Education • B.Tech, Mechanical Engineering, Indian Institute of Technology, Delhi • MBA, Business, Indiana University • MS, Mechanical Engineering, University of Illinois at Urbana-Champaign

	Director since 2020 Board Committees: • HC&CC • Corporate Governance			Swan Sit Ms. Sit brings extensive experience in digital transformation, digital strategy, marketing, and disruptive innovation to our Board. Ms. Sit currently acts as an independent business consultant to a number of private and public companies on various digital, marketing, and strategic initiatives. She is also a public speaker and content creator in the areas of business and technology. In her prior roles, Ms. Sit has built front-end consumer experiences across ecommerce, omnichannel, mobile, media, social, apps and innovation as well as integrated back-end operations.
				Current and Previous Experience • Swan Co., LLC (since 2019) • Nike (2018-2019) • Vice President, Global Digital Marketing • Vice President, Digital Capabilities, Business Operations & Service • Revlon & Elizabeth Arden (2015-2017) • Vice President, Global Digital			Public Company Boards • Novabay Pharmaceuticals (since 2019) • Nominating & Corporate Governance • Compensation Committee • Audit Committee Education • BA, Economics, Harvard University • MBA, Columbia Business School

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

	Director since 2024 Board Committees: • Audit • HC&CC			Stephanie Stahl Ms. Stahl brings significant marketing and strategy experience to our Board. She has significant business transformation, post-merger integration and public board leadership including M&A, DE&I and activist expertise. Ms. Stahl was formerly Executive Vice-President, Marketing & Strategy Officer at Coach, Inc. and Executive Vice-President and Chief Marketing & Strategy Officer at Revlon, Inc. and a partner and managing director at Boston Consulting Group. At Coach, Ms. Stahl led the creation of global brand strategy, messaging, marketing planning, development and implementation. She is the Co-Founder and former CEO of Ace of Air, a circular beauty and wellness brand, and is a Senior Advisor to Boston Consulting Group, Consumer & Climate. Ms. Stahl serves on three public company boards: Dollar Tree, Inc., where she chairs the Sustainability and Corporate Social Responsibility Committee, Carters, Inc., and Newell Brands Inc. She previously served on the boards of Knoll, Inc., where she chaired the Nominating, Governance and ESG Committee, and Founders Table, an L Catteron portfolio company.
				Current and Previous Experience • Studio Pegasus LLC (since 2015) • Boston Consulting Group • Senior Advisor & Executive Coach (since 2022) • Partner & Managing Director (1992-2003) • Coach, Inc. (2012-2015) • Executive Vice-President, Global Marketing & Strategy • Ace of Air (2017-2021) • Chief Executive Officer • Revlon (2003-2006) • Executive Vice-President & Chief Marketing and Strategy Officer			Public Company Boards • Dollar Tree, Inc. (since 2018) • Sustainability & Corp Social Responsibility Committee (Chair) • Carter’s Inc. (since 2022) • Newell Brands Inc. (since 2023) Past Public Company Boards • Knoll (2013-2021) Education • BS, Quantitative Economics, Stanford University • MBA, Harvard Business School

	Director since 2018 Board Committees: • Audit (Chair) • Corporate Governance			Gary Waring Mr. Waring brings to our Board extensive knowledge of financial accounting and reporting and the development of internal controls over financial reporting, as well as experience in strategic consulting and advising with acquisitions, divestitures, restructurings, and regulatory matters. Mr. Waring retired from Ernst & Young LLP in 2017 after serving more than 35 years with the firm in various positions including coordinating audit and business advisory services for more than 200 clients in the consumer products, retail, distribution, manufacturing and technology industries. Mr. Waring does not currently serve on any other public company board.
				Previous Experience • Ernst & Young LLP (1981-2017) • Assurance Partner			Education • BA, Accounting, Wittenberg University • Retired CPA • Former Member, American Institute of Certified Public Accountants • Former Member, California Society of Certified Public Accountants

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

STANDING COMMITTEES AND MEETINGS

Our Board oversees the management and affairs of our Company, as provided by Missouri law, and conducts its business through its meetings and its three standing committees: Audit Committee, Corporate Governance Committee, and HC&CC. In addition, from time to time, other committees may be established under the Board’s direction when necessary or advisable to address specific issues.

Set forth below is the current membership and descriptions of each of the standing committees, with the number of meetings held during the fiscal year ended September 30, 2024.

During fiscal 2024, all directors attended 100% of our Board meetings and over 80% of meetings of the committees on which they served at the time of their period of service. Under our Corporate Governance Principles, each director is highly encouraged to attend our annual meeting of shareholders each year. All directors in office during the 2024 Annual Meeting of Shareholders attended the meeting.

Each of the standing committees operates under a charter that was approved by our Board, copies of which are available on our website at www.edgewell.com, click on “Investors,” then “Corporate Governance” and select the Charter you wish to review.

Copies of the committee charters, our Corporate Governance Principles and our codes of conduct will be provided, without charge, to any shareholder upon request directed in writing to our Corporate Secretary, Edgewell Personal Care Company, 6 Research Drive, Shelton, Connecticut 06484.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

AUDIT COMMITTEE

		Members: Gary Waring (Chair), Robert Black, George Corbin, John Hunter, Stephanie Stahl
						Mr. Waring was appointed as the Chair of the Audit Committee in November 2018 and has been determined to be a financial expert, as defined by SEC guidelines.
		QUALIFICATIONS The Board has determined that all members of the Audit Committee meet heightened independence and qualification criteria and are financially literate as defined in the listing standards of the NYSE and SEC rules. Additionally, Mr. Waring qualifies as an “audit committee financial expert” as defined by the SEC. The Audit Committee met 6 times during fiscal 2024.				RESPONSIBILITIES • Review the audit, accounting, financial reporting and internal control functions. • Engage with and supervise our independent accountants. • Resolve differences between management and our independent accountants. • Establish procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or audit matters. • Oversee the Company’s overall risk management process and routinely discuss the Company’s risk profile, risk management, and risk exposures with management, internal auditors, and our independent registered public accounting firm. • Oversee the Company’s risk assessment and risk management policies, including those relating to cybersecurity and data protection as well as the Company’s cyber incident response plan. RECENT ACTIVITIES AND KEY FOCUS AREAS • As part of a systemic approach to Board oversight of ESG topics, the Committee continued its oversight of the Company’s key strategic, enterprise and cybersecurity risks and reviewed management’s evaluation of strategic and operating risks, including risk concentrations, mitigating measures, and the types and levels of risk. • Discussed the Board’s governance practices around cyber risk, in light of important new developments in the cyber landscape, including Artificial Intelligence, Data Privacy, and Emerging Technologies. • Reviewed various best practice cybersecurity governance processes and structures, in the context of the Committee’s current process, as well as additional or alternative approaches. • Discussed emerging domestic and global tax policy and reporting requirements. • Reviewed data and relevant metrics related to the Company’s employee relations center of excellence to identify trends, patterns and emerging risks, enabling proactive HR and employee relations strategies. • The Audit Committee also prepares the Report of the Audit Committee to be included in the Company’s proxy statement. At each meeting, representatives of PwC and the Vice President, Audit, Risk & Control are present to review accounting, control, auditing, and financial reporting matters. During certain of these meetings, the Audit Committee also held private sessions with the Company’s CFO, Chief Accounting Officer, Vice President, Audit, Risk & Control, and representatives of PwC. • The Board undertakes continuing education in emerging areas of interest to the Board and the Company. In 2024, for example, Directors attended a virtual half-day training session on AI Board Governance, supplemented with outside speakers on the topic throughout the year.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

HUMAN CAPITAL & COMPENSATION COMMITTEE

		Members: Rakesh Sachdev (Chair), Robert Black, George Corbin, Carla Hendra, James Johnson, Swan Sit, Stephanie Stahl
						Mr. Sachdev was appointed as the Chair of the HC&CC in February 2020.
		QUALIFICATIONS Our Board has determined that all members of our HC&CC are non-employee directors and are independent, as defined in the listing standards of the NYSE. No member of the HC&CC is or has been an officer or employee of our Company or any of our subsidiaries. No member has had any relationship with our Company or any other entity that requires disclosure under the proxy rules and regulations promulgated by the SEC. The HC&CC met 5 times during fiscal 2024.				RESPONSIBILITIES • Set the compensation of our executive officers. • Administer our stock incentive plans and grant equity-based awards. • Administer and approve performance-based awards under our executive officer bonus plan. • Establish performance criteria. • Monitor management compensation and benefit programs. • Review principal employee relations policies. • Review a risk assessment of our compensation policies and practices. • Oversight of the development, implementation, and effectiveness of the Company’s policies and strategies related to its human capital management. • Oversight of our Company’s policies in several environmental, social and governance areas, including human capital management, workplace safety, and teammate health and well-being. • Oversee talent acquisition, development and retention. • Oversee risks related to the development of and succession planning for the Company’s executive officers and risks associated with the Company’s compensation policies and practices. RECENT ACTIVITIES AND KEY FOCUS AREAS • As part of a systemic approach to Board oversight of ESG topics, the Committee continued formal oversight of the development, implementation, and effectiveness of the Company’s policies and strategies related to its human capital management, including matters related to diversity, equality, and inclusion, and talent management. • Conducted an in-depth review of the Company’s annual employee engagement survey, the key findings, opportunities for improvement, plans to address lower scores, as well as the key engagement drivers identified as items which would generate the greatest return on enhancing employee engagement. • Monitored, evaluated and determined appropriate fiscal 2024 STIP performance goals and results. • Performed an in-depth review and analysis of the Company’s incentive compensation plans in order to further align interests with those of our shareholders. • Provided oversight and guidance during the Company’s recent executive leadership changes in order to position the Company for continued growth. • Conducted an in-depth review of top next generation talent across business units, markets and functions to ensure a strong leadership pipeline and appropriate growth and development of the Company’s current and future leaders.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

CORPORATE GOVERNANCE COMMITTEE

		Members: James Johnson (Chair), Carla Hendra, Rakesh Sachdev, Swan Sit, Gary Waring
						Mr. Johnson was appointed as the Chair of the Corporate Governance Committee in February 2020.
		QUALIFICATIONS Our Board has determined that all members of our Corporate Governance Committee are non-employee directors, and are independent, as defined in the listing standards of the NYSE. The Corporate Governance Committee met 4 times during fiscal 2024.				RESPONSIBILITIES • Identify individuals qualified to become Directors. • Recommend to our Board nominees for election as directors, as well as committee memberships and compensation and benefits for directors. • Recommend Board committees and committee assignments, including assignments and succession planning for committee chairs. • Oversee our stock ownership guidelines for non-employee directors. • Conduct the annual self-assessment process of our Board and committees and facilitate Board education. • Review our Corporate Governance Principles and committee charters. • Monitor our Company’s positions and responses to significant public policy issues, including our compliance with applicable laws, and actions in furtherance of our corporate social responsibility objectives. • Oversee the Company’s policies in several environmental, social and governance areas, including our response to climate change, our ongoing efforts in ethical and responsible sourcing, and the embedding of human rights policies in our supply chain and global operations. • Oversee risks related to the Company’s corporate governance structure and processes, as well as risks related to public policy, social responsibility, environmental sustainability, and the Company’s reputation. • Review the external landscape of corporate governance practices and trends, including evolving shareholder expectations and key benchmarking data across similarly situated companies, and discuss the Company’s practices. RECENT ACTIVITIES AND KEY FOCUS AREAS • As part of a systemic approach to Board oversight of ESG topics, the Committee continued formal oversight of the development, implementation, and effectiveness of the Company’s policies and strategies related to sustainability goals, human rights and responsible sourcing, community impact efforts, and ESG impact on corporate reputation. • Continued ongoing review of short-term and long-term Board refreshment needs and ideal candidate skill, experience, and background profiles. • Oversaw the successful recruitment and onboarding of Stephanie Stahl as a new Board member.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

CORPORATE GOVERNANCE, RISK OVERSIGHT, SUSTAINABILITY AND DIRECTOR INDEPENDENCE

Board Structure and Practices

Social Responsibilities and Other
Shareholder Concerns

Risk Management and Compensation

		Our Board actively oversees our risk management practices, fostering a risk-aware culture while encouraging thoughtful risk taking
		Our Code of Conduct and Insider Trading Policy prohibit inappropriate trading activities, including hedging and pledging arrangements
		We have stock ownership requirements for Executive Leadership Team members and our directors
		Our Board engages in managing talent and long-term succession planning

		Our Board has an independent non-executive chairman
		Each of our Board members is elected annually
		We have majority voting for our director elections
		9 of our 10 Board nominees are independent
		We have adopted proxy notice and access, allowing shareholders access to our proxy materials online
		Our independent directors meet regularly in executive session
		Our Board and Committees engage in annual self-assessments and individual peer reviews
		Our Board continuously assesses refreshment

		We engage with our shareholders on key issues
		We post a Sustainability Report on our website
		We have articulated on our website our commitment to sustainability, gender equality and diversity, and human rights
		We have adopted a “Whistleblower” policy prohibiting company employees from retaliating or taking adverse action against anyone for raising a concern and we have an employee relations center of excellence that provides high quality, timely and objective investigations into HR-related and other business conduct issues raised through our ethics hotline and elsewhere, alleging violations of the law, Company policies, or principles of integrity/ethics/fairness.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Risk Oversight and Risk Management

Our Board, acting both directly and through its committees, is actively involved in oversight of the significant risks affecting our business. The risk oversight activities of our Board and committees are informed by our management’s risk assessment and risk management processes.

[MISSING IMAGE: fc_riskovermanag-pn.jpg]

Code of Conduct

The Company has a Code of Conduct that sets forth the fundamental principles and some of the key policies and procedures that govern our business. The Code of Conduct is reviewed each year for appropriate updates, and employees are asked to annually certify their understanding of, and compliance with, its requirements. As an integral part of our continuing efforts to maintain the highest standards of conduct, and because of the important role that each employee plays in our Ethics and Compliance Program, each year employees participate in mandatory compliance training meant to cover key components of the Code of Conduct and other relevant compliance topics related to our Company.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Moreover, at least annually, the Audit Committee reviews the Code of Conduct to ensure that the code reflects the highest ethical principles and standards. The Code of Conduct, which is firmly rooted in our Purpose, Values and Behaviors, is made available to employees in more than 10 different languages and can be found on the Company’s website at www.edgewell.com (information on the Company’s website is not incorporated by reference herein).

Business Practices and Standards of Conduct

Our Business Practices and Standards of Conduct are designed to provide guidance on and articulate our commitment to several key matters such as safety and health, protecting the environment, use of company resources, and promoting a harassment-free work environment. It also addresses certain legal and ethical facets of integrity in business dealings with suppliers, customers, investors and applicable laws and regulations.

Sustainable Care 2030

Guided by our Sustainable Care 2030 strategy, we are on a journey to continually do better and be better — working toward our goals with a clear eye to the future. The strategy comprises three pillars and 10 commitments in areas where we believe we have the greatest potential for positive impact. It’s the driving force behind our efforts to innovate our brands, responding to the explicit demands of our customers, to evolve our operations for reduced environmental impact and to continue finding ways to create a positive impact for people and communities.

Brands: Innovating products and packaging; championing values of diversity, equity and inclusion (DEI); and using our brands as a catalyst for good

Operations and Supply Chain: Reducing our environmental footprint with a focus on greenhouse gas (GHG) emissions, energy, waste and water; responsibly sourcing materials; and engaging suppliers on ethical and sustainable practices

People and Communities: Living our values and uplifting teammates, customers, consumers, suppliers and communities.

Our Board of Directors is directly engaged in overseeing our climate, ethical and responsible sourcing and human capital practices, among other topics. This is then embedded at all other levels of the organization, fueling a continued focus on our goals.

You can read more about our progress within each of these pillars and toward our commitments in our Fiscal Year 2023 Sustainability Report, which is available on our website, www.edgewell.com, click on “Our Company,” then “Sustainability,” then “Find Out More In Our FY23 Sustainability Report.”

Respecting Human Rights

Promoting fair, inclusive work environments for our own teammates and our suppliers’ employees is something that matters deeply to us. Key to this is respecting human rights and promoting sustainable business practices across our global operations and supply chain. We recognize that our potential human rights impacts go beyond our own operations into our supply chain. As such, we are continually reviewing and improving our Ethical and Responsible Sourcing program to ensure alignment between our Human Rights Policy and business activities. Included in our annual Edgewell Code of Conduct training is a human rights module to ensure our teammates understand our stance and expectations. We also require that business partners comply with our Supplier Code of Conduct, and expect they cascade their commitment to respect human rights to other business relationships throughout their own supply chains.

Ethical and Responsible Sourcing

Edgewell strives to promote sustainable business practices across our entire value chain. We believe in working with organizations that share our values and expect our suppliers and business partners to uphold ethical business practices.

We detail our expectations — and conditions for partnering with Edgewell — in our Supplier Code of Conduct. This includes, but is not limited to, standards related to:

•

Labor and human rights (including nondiscrimination, forced labor, child labor, working hours, wages, benefits and freedom of association)

•

Environmental management

•

Health and safety

•

Ethics and anti-corruption

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Edgewell does not tolerate modern slavery or human trafficking either in our own teams or those of our suppliers. Additionally, we communicate regularly with suppliers, customers and other stakeholders around our sourcing practices, including supporting customers with their sustainability priorities. Moreover, at least annually, the Audit Committee of our Board reviews the Supplier Code of Conduct to ensure that it continues to reflect the highest ethical principles and standards we expect of our suppliers.

We assess global compliance with these policies annually.

Director Independence

Edgewell’s Corporate Governance Principles define our standards for director independence and reflect applicable NYSE and SEC requirements. For a director to be “independent,” they must not have a material relationship with the Company, as reviewed by the Corporate Governance Committee and determined by the Board.

Director affiliations and transactions are regularly reviewed to ensure that there are no conflicts or relationships with our Company that might impair a director’s independence. Every year, we submit a questionnaire to each director and executive officer, in addition to conducting our own internal review, for the purpose of identifying certain potentially material transactions or relationships between each director, or any member of their immediate family, and our Company, our senior management and our independent auditor.

The Corporate Governance Committee completed its annual assessment in October 2024 regarding the independence of each director and made recommendations to the Board. Consistent with the standards described above, the Board has reviewed all relationships between the Company and each director and director nominee and considered all relevant quantitative and qualitative criteria. The Board has affirmatively determined that, other than Mr. Little who serves as our President and CEO, all director nominees are currently independent. In addition, the Board affirmatively determined that all of the director nominees who currently serve on the Audit Committee and the HC&CC are independent as required by the heightened NYSE and SEC criteria referenced above.

Our Board also determined that no arrangement or understanding exists between any director or executive officer of our Company and any other person pursuant to which any of them were selected as a director or executive officer. Accordingly, based on the responses to the 2024 questionnaire and the results of its review, our Board has affirmatively determined that all directors, other than Rod Little, are independent from management.

Director Nominations

The Corporate Governance Committee is responsible for recommending candidates for election to our Board of Directors, consistent with the requirements for membership set forth in our Corporate Governance Principles. Historically, when vacancies have occurred, or when our Board determined that increasing its size was appropriate, candidates have been recommended by other Board members or our CEO, or the Board has engaged the services of a recruitment firm to assist with conducting a search. In evaluating potential director candidates, the Corporate Governance Committee considers, among other factors, the criteria in the Key Skills and Experience matrix for current directors and certain additional characteristics that it believes one or more directors should possess based on an assessment of the needs of the Board at that time. The priorities for recruiting new directors are continually evolving based on the Company’s strategic needs. It is important that the Board remains a strategic asset capable of overseeing and helping management address the risks, trends, and opportunities facing our Company now and in the future. The Corporate Governance Committee continues to plan for the future as it considers the skills and experience the Board will need upon anticipated director retirements and as our business continues to evolve.

The Corporate Governance Committee expects a high level of commitment from Board members and evaluates each candidate’s leadership and experience, skills, expertise and character traits, including the candidate’s ability to devote sufficient time to Board and committee meetings in light of other professional commitments. The Committee also reviews whether a potential candidate meets Board and/or committee membership requirements, as set forth in our Corporate Governance Principles, determines whether a potential candidate is independent according to our Board’s established criteria, and evaluates the potential for a conflict of interest between the director and our Company.

Although our Company does not have a formal policy with respect to diversity matters, our Board considers factors such as diversity on the basis of race, color, national origin, gender, religion, disability and sexual orientation. The Corporate Governance Committee reviews its effectiveness in balancing these considerations when assessing our Board’s composition. The Corporate Governance Committee is also responsible for articulating and refining specific criteria for Board and committee membership to supplement, as appropriate, the more general criteria set forth in our Corporate Governance Principles. Currently, 71% of the HC&CC and 80% of the Corporate Governance Committees, including the Chairs of the HC&CC and Corporate Governance Committee, are ethnically and/or gender diverse. Of the ten nominees for election to the Board at the 2024 Annual Meeting, 50% are ethnically and/or gender diverse.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Following a rigorous search for qualified candidates based on the above qualifications and criteria, Ms. Stahl was appointed to our Board effective September 10, 2024 following the recommendation by a non-management director and an extensive interview process. Our Board continues to believe it is paramount to maintain flexibility in the nominating process in order to ensure that the most appropriate available candidates are selected as circumstances dictate and the needs of the Company evolve.

Under our bylaws, shareholders may also nominate candidates for election at an annual meeting of shareholders. See “Shareholder Proposals for the 2026 Annual Meeting” for details regarding the procedures and timing for the submission of such nominations. Director nominees submitted through this process will be eligible for election at the annual meeting but will not be included in our Company’s proxy materials prepared for the meeting.

Non-Employee Director Stock Ownership Guidelines

In order to help align the financial interests of our non-employee directors with those of our shareholders, our Corporate Governance Principles provide that our non-employee directors must maintain ownership of our common stock with a value of at least five times the director’s annual base retainer, excluding any supplemental amounts for the roles of Non-Executive Chairman and committee chair. New directors are given a period of five years to satisfy these requirements. The Company recognizes that there may be instances when these guidelines would place an undue hardship on a non-management director. The Chairperson of the Corporate Governance Committee may, in their discretion, determine the appropriate hardship relief, if any, for non-compliance with our stock ownership guidelines, including but not limited to allowing individuals additional time to gain or regain compliance and suspending ownership or retention requirements in the event of extreme volatility in the Company’s common stock price. The Corporate Governance Committee may modify or amend the stock ownership guidelines in its discretion.

The Corporate Governance Committee reviews our non-employee director stock ownership guidelines and ownership levels each year to ensure compliance with the provisions of our Corporate Governance Principles. All directors were in compliance as of September 30, 2024.

For purposes of these determinations, stock ownership includes shares of our common stock which are owned directly or by family members residing with the director, or by family trusts, as well as vested and deferred restricted stock equivalents and unvested restricted stock equivalents, unless they are subject to achievement of performance targets, and common stock or stock equivalents credited to a director under our savings investment plan or our deferred compensation plan.

Communicating Concerns to our Board

We have established several means for shareholders or others to communicate their concerns to our Board. If the concern relates to our financial statements, accounting practices or internal controls, the concern should be submitted in writing to the chair of our Audit Committee, in care of our Corporate Secretary at our headquarters address, 6 Research Drive, Shelton, Connecticut 06484 or via email to investor.relations@edgewell.com. If the concern relates to our governance practices, business ethics or corporate conduct, the concern may be submitted in writing to the chair of our Corporate Governance Committee, in care of our Corporate Secretary at our headquarters or email address. If the shareholder is unsure as to which category his or her concern relates, he or she may communicate it to any one of the independent directors in care of our Corporate Secretary at our headquarters or email address.

Our “whistleblower” policy prohibits our Company or any of our employees from retaliating or taking any adverse action against anyone for raising a concern. If a shareholder or employee nonetheless prefers to raise his or her concern in a confidential or anonymous manner, he or she may call Navex Global’s EthicsPoint hotline, our external service provider, toll-free at 855-405-6557, or by leaving a message at our confidential web address: www.edgewell.ethicspoint.com.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

NON-EMPLOYEE DIRECTOR COMPENSATION

We provided several elements of compensation to our directors for service on our Board during fiscal 2024 as shown in the table below. The Corporate Governance Committee, which makes recommendations to the full Board regarding director compensation, strives to set director compensation at the 50th percentile of the peer group. This peer group, which can be found under “Executive Compensation — Compensation Discussion and Analysis — Compensation Benchmarking,” has been selected for purposes of evaluating our executive compensation based on market data provided by the committee’s independent consultant, Meridian Compensation Partners, LLC (“Meridian”). Following discussion and consultation with Meridian, the Board determined that there would be no modifications to the existing non-employee director compensation.

Elements of Non-Employee Director Compensation for Fiscal 2024
Compensation Elements	Compensation Amounts
Annual Retainer (1)		$	100,000
Chair of the Board Additional Annual Retainer		$	115,000
Committee Chair Annual Retainers
Audit Committee		$	20,000
HC&CC		$	20,000
Corporate Governance Committee		$	20,000
Annual Restricted Stock Equivalent Award (2)		$	145,000
New Director Restricted Stock Equivalent Award (3)		$	100,000

(1)

All non-employee directors receive an annual retainer for serving on our Board and its committees. Mr. Little receives no compensation for his service on our Board other than his compensation as the President and Chief Executive Officer of our Company.

(2)

All non-employee directors receive an annual restricted stock equivalent award under our Second 2018 Amended & Restated Stock Incentive Plan (“2nd A&R 2018 Plan”) immediately following the annual meeting of shareholders. This award vests one day prior to the following year’s annual meeting. Directors have the option to defer the delivery of shares upon vesting of this award.

(3)

New non-employee directors that may be appointed or elected to our Board receive an initial restricted stock equivalent award. This award vests three years from the date of grant.

Non-employee directors are permitted to defer all or a portion of their retainers and fees under the terms of our deferred compensation plan. Deferrals may be made into (i) the Edgewell common stock unit fund, which tracks the value of our common stock; or (ii) the prime rate option, under which deferrals are credited with interest at the prime rate quoted by The Wall Street Journal. Deferrals in the deferred compensation plan are paid out in a lump sum in cash within 60 days following the director’s termination of service on the Board.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

NON-EMPLOYEE DIRECTOR COMPENSATION FOR FISCAL 2024

Name	Fees Earned or Paid in Cash (1)			Stock Awards (2)			All Other Compensation (3) (4)			Total
Robert W. Black		$	100,000		$	145,000		$	1,991		$	246,991
George R. Corbin		$	100,000		$	145,000		$	0		$	245,000
Carla C. Hendra		$	100,000		$	145,000		$	344		$	245,344
John C. Hunter, III		$	215,000		$	145,000		$	0		$	360,000
James C. Johnson		$	120,000		$	145,000		$	0		$	265,000
Joseph D. O’Leary		$	100,000		$	145,000		$	1,991		$	246,991
Rakesh Sachdev		$	120,000		$	145,000		$	0		$	265,000
Swan Sit		$	100,000		$	145,000		$	0		$	245,000
Stephanie Stahl		$	8,333		$	148,333		$	0		$	156,666
Gary K. Waring		$	120,000		$	145,000		$	796		$	265,796

(1)

This column reflects retainers earned during fiscal 2024. Ms. Sit elected to defer the cash retainer fees paid to her in fiscal 2024. Ms. Stahl’s compensation is prorated as of September 10, 2024.

(2)

This column reflects the aggregate grant date fair value, in accordance with FASB, ASC Section 718, of the RSE awards granted on February 1, 2024 under our 2nd A&R 2018 Plan as described in the narrative above. Refer to “Note 15. Share-Based Payments” of the Notes to Consolidated Financial Statements of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024 for further discussion. The number of unvested RSEs held by our directors as of September 30, 2024, was as follows: Messrs. Black, Corbin, Hunter, Johnson, O’Leary, Sachdev, and Waring and Mss. Hendra and Sit, 3,853; and Ms. Stahl, 4,113 (2,773 and 1,340 shares granted on September 10, 2024). The number of vested RSEs deferred until retirement from our Board held by the directors as of September 30, 2024, was as follows: Mr. Black, 3,944; Mr. Corbin, 6,693; Ms. Hendra, 6,731; Mr. Hunter, 22,709; Mr. Johnson, 26,225; Mr. O’Leary, 3,156; Mr. Sachdev, 24,323; Mss. Sit and Stahl, 0; and Mr. Waring, 17,755.

(3)

The following items are not included within the above disclosure of director compensation:

(i)

The directors are covered under the terms of our general directors’ and officers’ liability insurance policies, the premiums for which are a general expense of our Company. We do not obtain a specific policy for each director or for the directors as a group.

(ii)

We provide transportation and lodging for out-of-town directors attending Board and committee meetings.

(iii)

The non-employee directors may be provided from time to time with samples of our products with an incremental cost of less than $50.

(4)

This column reflects dividends payable to the non-employee directors for vested accrued restricted stock equivalents.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

A Clear Path for Sustainable Growth

In 2020, amid the ongoing COVID-19 pandemic and with much uncertainty around the globe, we pressed forward with an aggressive set of objectives and launched a growth strategy we believed would fundamentally reshape our portfolio and provide a clear path for sustainable, profitable growth.

We will transform into a growing, sustainable and consumer-centric personal care company and we will drive stable topline and accelerated profit growth and predictable cash generation, delivering a meaningful total shareholder return

A Compelling Strategy — Launched Investor Day November 2020

Our results in fiscal 2024 further demonstrate the progress we are making in transforming our business, and the effectiveness of the strategy and business model we launched just under 4 years ago. Despite a meaningfully more challenged “Right to Play” portfolio in the U.S., fiscal 2024 results reflect our commitment to deliver on our broader profit ambition. As such, despite a topline performance that fell below our expectations, we delivered Adjusted EBITDA and Adjusted EPS well above prior year results and at the high end of our original earnings guide, with free cash flow also exceeding prior year results.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Note: Certain amounts and percentages may not sum or recalculate due to rounding.

While the results we posted this year demonstrate that our overall strategy is gaining increasing traction, our journey and transformation of the business is not complete. As a result, in August, we announced a series of leadership team and organizational changes designed to strengthen our operating model, streamline decision making and improve enterprise execution, all of which we believe will better position us to deliver on our overarching strategy to drive sustainable top- and bottom-line growth.

As we look to fiscal 2025, with good momentum across our international businesses and Right to Win portfolio, a strengthened leadership team, and increased focus on execution across the organization, we would like to share what you can expect from Edgewell in fiscal 2025 and beyond.

[MISSING IMAGE: fc_strongbusiness-4clr.jpg]

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

AUDIT COMMITTEE REPORT

The Audit Committee of Edgewell’s Board of Directors assists the Board in its oversight of corporate governance by overseeing the quality and integrity of Edgewell’s accounting, auditing, and reporting practices. The Audit Committee operates in accordance with a written charter, which was adopted by the Board. A copy of that charter is available at Edgewell’s Investor Relations site, http://ir.edgewell.com/, under “Corporate Governance.” The Audit Committee consists entirely of non-employee directors that are independent, as required by the listing standards of the NYSE and the rules and regulations of the SEC. Further, the Board has determined that Mr. Waring is an audit committee financial expert, as defined by SEC guidelines.

Management is responsible for the Company’s internal controls and the financial reporting process. Edgewell’s independent accountants, PwC, are responsible for performing an independent audit of the Company’s consolidated financial statements and internal control over financial reporting in accordance with the standards established by the Public Company Accounting Oversight Board (United States) (the “PCAOB”) and issuing a report thereon. The committee’s responsibility is to monitor and oversee these processes on behalf of the Board.

The Audit Committee has oversight responsibilities for reviewing the services performed by PwC and retains sole authority to select, evaluate and replace the outside auditors. The Audit Committee is responsible for approval of the proposed audit fees and annually evaluates the qualifications, performance and independence of PwC and its lead audit partner. Further, in conjunction with the mandated rotation of the independent auditor’s lead audit partner, the Audit Committee is directly involved in the selection of the new lead audit partner.

The Audit Committee has received the written disclosures from PwC required by the applicable standards of the PCAOB regarding the independent accountant’s communications with the Audit Committee concerning independence and has discussed the independence of PwC with members of that firm. In doing so, the committee considered whether the non-audit services provided by PwC were compatible with its independence. The committee concluded that the independent auditors’ independence has not been impaired. The Audit Committee selected PwC as the Company’s independent registered public accountants for fiscal year 2025, subject to shareholder ratification. PwC has served as the Company’s independent registered public accounting firm since 2000, and fiscal year 2025 is the fourth year for the current lead partner who will rotate off after completion of the fiscal year 2025 audit. The Audit Committee considered several factors in selecting PwC, including the firm’s independence and internal quality controls, the overall depth of talent, their experience with the Company’s industry, their familiarity with the Company’s business and internal control over financial reporting, as well as an evaluation of their past performance and the potential impact of changing independent auditors.

In fulfilling its oversight responsibilities, the Audit Committee meets regularly with management, internal audit and PwC to discuss, prior to their release to the public, the Company’s financial statements and earnings releases and, as appropriate, other Company public communications containing Company financial information or performance measures. The Audit Committee’s meetings with the Company’s internal auditors and the independent registered public accounting firm, which are both with and without management present, include discussions about the results of their examinations and evaluations of the quality of the Company’s financial statements and the Company’s internal control over financial reporting.

The Audit Committee has reviewed with management the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2024. This review included a discussion of the quality and the acceptability of the Company’s financial reporting and system of internal controls, including the clarity of disclosures in the financial statements, reasonableness of significant accruals, reserves and allowances, critical accounting policies and estimates, and risk assessment. With respect to the Company’s audited financial statements for the fiscal year ended September 30, 2024, management of the Company has represented to the committee that the financial statements were prepared in accordance with generally accepted accounting principles.

In addition, the Audit Committee reviewed and discussed with the Company’s independent registered public accounting firm the scope and plans for their audit, the audited financial statements of the Company for the fiscal year ended September 30, 2024, the independent registered public accounting firm’s judgments as to the quality and acceptability of the Company’s financial reporting, PwC’s discussion about critical audit matters in its report on the audited financial statements for the fiscal year ended September 30, 2024, the Company’s critical accounting policies and estimates, the effectiveness of the Company’s internal control over financial reporting and such other matters as are required to be discussed by the applicable requirements of the PCAOB and SEC.

Based on the review and discussions referred to above, the Audit Committee recommended to the Company’s Board of Directors that the audited financial statements for the fiscal year ended September 30, 2024 be included in the Company’s Annual Report on Form 10-K for that year for filing with the SEC.

Respectfully submitted,

Gary K. Waring, Chair
Robert W. Black
George R. Corbin
John C. Hunter, III
Joseph D. O’Leary
Stephanie Stahl

No portion of this Audit Committee Report shall be deemed to be incorporated by reference into any filing under the Securities Act of 1933 (the “Securities Act”), the Securities Exchange Act of 1934 (the “Exchange Act”), or through any general statement incorporating by reference in its entirety the Proxy Statement in which this report appears, except to the extent that the Company specifically incorporates this report or a portion of it by reference. In addition, this report shall not be deemed to be filed under either the Securities Act or the Exchange Act.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION DISCUSSION AND ANALYSIS

CD&A TABLE OF CONTENTS

	EXECUTIVE COMPENSATION					23
	NEO Snapshot					24
	Fiscal 2024 Performance Highlights					24
	Principles of the Edgewell Compensation Program					25
	Compensation Policies and Governance Practices					27
	Compensation Benchmarking					28
	Results of 2024 Advisory Vote to Approve Executive Compensation					29
	Summary of Key Elements of Executive Compensation in Fiscal 2024					29
	Performance Measures Driving 2024 Compensation					29
	Elements of Compensation					30
	Short-Term Incentive Program – Annual Cash Bonus					31
	Historical Pay-for-Performance Table					33
	Long-Term Incentive Program – Equity Awards					33
	Executive Officer Stock Ownership Requirements					36
	Anti-Hedging Policy					36
	Incentive Compensation Recoupment Policy					36
	Executive Compensation Tables					38
	Summary Compensation Table					38
	Grants of Plan-Based Awards					41
	Outstanding Equity Awards at Fiscal Year End					43
	Option Exercises and Stock Vested					46
	Pension Benefits					46
	Non-Qualified Deferred Compensation					47
	Human Capital & Compensation Committee Report					48
	Potential Payments Upon Termination or Change in Control					49
	Death, Permanent Disability or Termination of Employment					49
	Executive Severance Plan					50
	Change in Control of the Company					51
	Chief Executive Officer Pay Ratio Disclosure					53
	Equity Compensation Plan Information					54

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Composition of our NEOs in Fiscal 2024

The following narratives and tables discuss the compensation paid in fiscal 2024 to our CEO, CFO, and our other three most highly compensated executive officers who served during fiscal 2024, whom we refer to collectively as our “named executive officers.” This year’s NEOs are shown below:

		NEO				Role
		Rod R. Little				President and Chief Executive Officer since March 2019
		Daniel J. Sullivan (1)				Chief Operating Officer and Chief Financial Officer since August 2024
		Eric F. O’Toole (2)				Former President, North America
		LaTanya Langley (3)				Chief People Officer, Chief Legal Officer and Secretary since November 2023
		John N. Hill (4)				Former Chief Human Resources Officer

(1)

Mr. Sullivan has served as Chief Financial Officer since April 2019. Mr. Sullivan has served as Chief Operating Officer and Chief Financial Officer from August 6, 2024 until December 1, 2024, at which time he assumed the role of Chief Operating Officer only.

(2)

Mr. O’Toole left the Company effective November 15, 2024.

(3)

Ms. Langley has served as our Chief Legal Officer since February 2022. Ms. Langley has served as our Chief People Officer, Chief Legal Officer and Secretary since November 2023.

(4)

Mr. Hill retired from the Company effective January 5, 2024.

Fiscal 2024 Highlights:

Our results in fiscal 2024 further demonstrate the progress we are making in transforming our business, and the effectiveness of the strategy and business model we launched just under 4 years ago.

In the face of a heightened competitive landscape and an increasingly cautious consumer, we accelerated organic growth across our international businesses, introduced category-leading innovation in the US suncare category and deepened our participation globally across the men’s and women’s grooming segments. As inflation normalized, we saw meaningful flow through from our productivity and pricing initiatives, both key pillars of our business model which drove strong bottom-line results. We delivered healthy earnings growth, and our substantial cash flow generation supported our efforts to both de-lever and buy back shares.

We’ve been relentless on productivity efforts, disciplined on cost and cash management, and increasingly agile in price and revenue management, all of which will continue to be at the core of how we will manage our business going forward.

We have always maintained a disciplined, multi-dimensional approach to capital allocation, and while we continue to prioritize investing in the sustained growth of our business, we remain equally focused on providing strong returns for our shareholders. In fiscal 2024 we continued to put our healthy excess cash to work, paying $31 million in dividends to our shareholders. In addition, with our strong liquidity and credit position and outlook for continued healthy free cash flow generation, we implemented a more systemic approach to share repurchases to complement the dividend. In fiscal 2024, we returned $59 million to our shareholders through share repurchases.

People First

We believe our foundational values of “People First,” “Move Forward,” “Listen Up and Speak Up” and “Own It Together” support a culture of celebration, agility, authenticity, inclusion, and collaboration. This culture promotes trust and teamwork, which results in bold and aggressive goals, smart risks, and an environment where innovation and ideation thrive.

We continue to reinforce these foundational values through several key initiatives such as our performance management process which incorporates a ‘360-degree Values Assessment’ that evaluates each employee’s performance not only on the results achieved, but on how they achieve them and an internal global recognition and service anniversary platform. We understand that to attract and retain great people, we must listen to and engage them regularly. Each year, we conduct an anonymous employee experience survey to gauge our progress and identify the areas in the employee experience where we excel and areas for improvement. Our overall positivity score has continued to increase year-over-year. Specifically, confidence in Edgewell’s future, a sense of belonging, and a belief that Edgewell provides opportunities to achieve a meaningful work-life balance all increased year over year. In addition to global themes, our employee experience

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

survey results identified diverse priorities at the functional, country, and team levels. Our goal is to support our People Managers in taking accountability for their results and to empower them to make changes at a local level to improve the employee experience.

As recognition of the progress we’ve made in living our foundational values, we have received notable recognition in the following ways:

•

Recognized as one of America’s Most Responsible Companies by Newsweek and Statista for the fifth year running. In 2024, we rose to #19 overall — and #3 in our industry.

•

Ranked #2 out of 400 companies listed on Forbes America’s Best Midsize Employers in 2024 — our first time being listed and a testament to our commitment to being a people-first employer.

•

Recognized by USA Today and Statista among their list of America’s Climate Leaders in 2024.

•

Recipient of the Environmental Protection Agency’s SmartWay Excellence Award as a true industry leader in freight and supply chain.

How Pay Was Tied to our Company’s Performance in Fiscal 2024

Our fiscal 2024 results and compensation decisions continue to illustrate the application of our pay-for-performance philosophy, with pay being driven by performance in the following ways:

•

Fiscal 2024 Base Salary. In November 2023, the HC&CC increased base salaries for the existing named executive officers for fiscal 2024 to ensure that compensation remains competitive with comparable positions at companies considered to be our peers, while continuing to emphasize pay-for-performance.

•

Fiscal 2024 Annual Incentive Payout. For the fiscal 2024 Executive Officer Bonus Program, the combined weighted payout for the NEOs was 97% of the target amount.

•

Fiscal 2024 Long-Term Incentive Payout. The performance metrics for our fiscal 2021 Long-Term Incentive award was relative total shareholder return (TSR). The total payout for these PRSEs was 99.8% of target.

See Appendix A for reconciliation and other information about these non-GAAP financial measures.

Principles of the Edgewell Compensation Program

We believe one of the most important factors to the long-term success of Edgewell depends on the talents of our executive officers and the alignment of their compensation with the interests of the Company and our shareholders. Our ability to attract, retain, and motivate our executive officers is influenced in large part by our compensation program. Annually, we review various aspects of our compensation program to ensure that it remains aligned with our business strategy and the above-referenced goals. The guiding principles of our compensation program include:

•

A “pay-for-performance” culture, which drives achievement of Company-wide performance criteria during one- and three-year performance periods and, ultimately, shareholder value;

•

We strive to attract and retain diverse and strong executive leaders and target total compensation packages which we believe will serve to retain key executives and remain competitive in attracting new employees; and

•

Alignment of our executive officer’s interests with those of our shareholders by linking a significant portion of total compensation to shareholder value creation, with our executive leadership’s performance outcome tied to our stock performance benchmarked against a selected peer group which we believe incentivizes sustained company performance as measured by operating results and total shareholder return.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

We believe the design and implementation of our compensation program is effective in furthering our goal of becoming a best-in-class, next-generation CPG company. Discussed below are the principles that underlie our compensation philosophy.

Pay-for-Performance

The primary goal of our compensation program is to instill a “pay-for-performance” culture throughout our organization, with a significant portion of targeted compensation for our NEOs dependent upon achievement of performance goals and forfeited if goals are not achieved. Our compensation program is designed to motivate these leaders through incentive awards that are tied to key strategic objectives and operating results and execution of significant initiatives. We believe this compensation structure offers high potential rewards for superior performance, and significantly lower compensation for results below target.

	CEO Target Pay Mix			Other NEO Target Pay Mix

Note: The $8,044M is cumulative, not an average.

Competitive Total Compensation Packages

We strive to attract and retain diverse and strong executive leaders, which we view as critical to the ongoing success of our operations. We target total compensation packages which we believe will serve to retain key executives and remain competitive in attracting new employees. Our executive compensation program also includes features to address other compensation-related issues such as retirement concerns, which we believe have played an important role in our executive compensation structure.

Alignment with Shareholder Interests

In order to align the compensation received by our executives with the returns received by our shareholders, a substantial portion of the NEOs’ total compensation has historically been through vesting of performance-based and time-based restricted stock equivalents and stock options. Our incentive compensation program focuses on a combination of short- and long-term metrics which motivate the achievement of our Company’s performance targets. We further align the interests of our executive officers and shareholders through our use of stock ownership guidelines and prohibitions on hedging or pledging as collateral of Edgewell common stock.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Compensation Policies and Governance Practices

As part of its responsibilities, the HC&CC annually reviews our Company’s compensation policies and practices to determine whether, in its judgment, our compensation programs encourage risk-taking reasonably likely to have a material adverse effect on our Company. In particular, there are several design features of those programs that the HC&CC believes reduces the likelihood of excessive risk-taking:

WHAT
WE DO

✓ Deliver executive compensation primarily through performance-based at-risk pay, with a balance of annual and longer-term incentives.

✓ Maintain a peer group for benchmarking pay.

✓ Place a cap on payout levels for bonuses and performance awards.

✓ Tie performance metrics for the executive compensation program to key, auditable measures.

✓ Set performance goals at levels that are sufficiently high to encourage strong performance, but within reasonably attainable parameters intended to discourage pursuit of excessively risky business strategies.

✓ When appropriate, exercise negative discretion to reduce incentive payments in certain circumstances when determining performance-based compensation.

✓ Maintain a recoupment (clawback) policy for short- and long-term incentive programs, as well as an anti-hedging/pledging policy.

✓ Require share ownership and retention guidelines for executive officers.

✓ Use “double-trigger” change in control arrangements under our 2nd A&R 2018 Plan and our Change in Control Plan.

✓ Use an independent consultant to advise on compensation levels, trends and practices and assist the board in assessing the level of risk created by or embedded in our various compensation and benefit plans.

WHAT WE
DON’T DO

✘ Guarantee annual salary increases or bonuses.

✘ Allow directors or executives to engage in hedging or pledging of securities.

✘ Reward executives for excessive, inappropriate or unnecessary risk-taking.

✘ Allow tax gross-ups.

✘ Allow repricing of stock options.

✘ Allow excessive perquisites.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

How We Make Compensation Decisions

Compensation Benchmarking

Meridian, with direction from the HC&CC, develops a custom peer group of companies against which the HC&CC benchmarks our compensation program. Peer companies are selected based on a variety of criteria, including consumer products businesses, businesses with a strong brand focus, competitors for executive talent, businesses similar to Edgewell in terms of revenues and market capitalization, and externally referenced peers from proxy advisory firms and reverse peers. At the time of approval, Edgewell ranked near the median of our executive compensation peer group on revenue, market cap, and EBITDA. Each key component of compensation, including base salary, target annual bonus, target total cash compensation, and target grant date value of long-term incentives, is benchmarked against this custom peer group.

For fiscal 2024, Revlon, Inc., and McCormick & Company, Incorporated were removed and Coty, Inc. was added. Revlon Inc. was taken private in April 2023 and McCormick & Company was no longer considered an appropriate peer based on revenue and market capitalization and business profile. Coty, Inc. was added based on size and business fit. The custom peer group of 17 companies approved by the HC&CC for fiscal 2024 is comprised of the following companies:

■ Church & Dwight Co., Inc.	■ Helen of Troy Limited	■ Spectrum Brands Holdings, Inc.
■ Coty Inc.	■ Nu Skin Enterprises, Inc.	■ The Clorox Company
■ Energizer Holdings, Inc.	■ Oxford Industries, Inc.	■ The Hain Celestial Group, Inc.
■ Fossil Group, Inc.	■ Prestige Brands Holdings, Inc.	■ Tupperware Brands Corporation
■ HanesBrands, Inc.	■ Post Holdings, Inc.	■ USANA Health Sciences
■ Hasbro, Inc.	■ Sleep Number Corporation

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Results of 2024 Advisory Vote to Approve Executive Compensation

Over the long term, shareholders have expressed support for our executive compensation program design and its demonstrated linkage of pay-for-performance. Our 2024 Say-on-Pay proposal received support from 83.6% of shareholder votes cast, reflecting our continued engagement with shareholders and stakeholders to help the Board and management continue to refine our executive compensation program to reflect evolving best practices in the CPG industry and for public companies more generally. The HC&CC recognizes that enhancing the compensation program is critical for ensuring the continued alignment of management and our shareholders’ interests.

Summary of Key Elements of Executive Compensation in Fiscal 2024

Principal Components of Named Executive Officer Compensation

Performance Measures Driving Fiscal 2024 Compensation

Short-Term Incentive Plan

	Adjusted EBITDA				Adjusted Net Sales				Strategic Priorities Achieved
	$353.1M Target of $340.0M				$2,241.2M Target of $2,305.0M				4 Target of 4

Long-Term Incentive Plan

	Relative TSR (Quarterly Average)
	99.8% Payout versus 50th Percentile Target

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Elements of Compensation

The key elements of our fiscal 2024 executive compensation program as well as the purpose of each item are shown in the following table:

Base Salary

Annual Cash
Bonus

Long-term Incentives

RSE Awards

PRSE Awards

Option Awards

Purpose

Attract and retain key individuals while reflecting contribution, background, knowledge, skills and performance

An annual cash incentive based on the achievement of Company financial goals and individual performance

Align NEO and shareholder interests by promoting achievement of longer-term company-wide performance goals

Align NEO and shareholder interests by tying a significant portion of compensation to the performance of our common stock

Align NEO and shareholder interest in stock appreciation

Performance
Period

– – – – –

One Year
10/1/2023 –
9/30/2024

Three Year
Vesting Ratably

Three Year
Cliff Vesting
10/1/2023 –
9/30/2026

Three Year
Vesting Ratably
10 Year Term

Performance
Metrics

– – – – –

• Adjusted EBITDA

• Adjusted Net Sales

• Strategic Priorities

Time-vesting RSE awards will vest in equal installments on each of the first three anniversaries of the grant date

Relative Total Shareholder Return

Absolute stock price appreciation

Base Salary. We benchmark base salary against our peer group annually as a guide to setting compensation for key positions, including the Named Executive Officers, in the context of prevailing market practices. Pay decisions take into account results delivered in the prior fiscal year in addition to pay positioning relative to competitive peer benchmarks.

At the beginning of each fiscal year, the HC&CC establishes the salaries of the executive officers (other than our CEO) based on several factors, including peer group data, the executive’s performance and potential, retention considerations, and the recommendations of our CEO. These recommendations are based on, among other factors, an assessment of the individual’s responsibilities, experience, and individual performance.

The salary of our CEO is set by the Board, based upon the recommendation of the HC&CC, taking into account Meridian’s recommendation. In connection with those reviews, Meridian, without input from management, provides the HC&CC with a competitive market analysis, based on the approved peer group for salary, bonus and long-term incentive award levels. The HC&CC uses this information, along with its analysis of the performance and contributions of our CEO against performance goals, to recommend to our Board an appropriate salary for our CEO.

The HC&CC evaluated the annual base salaries of the individuals then serving as executive officers at its November 2023 meeting and set the base salaries of the following NEOs:

Name	Fiscal 2023 ($)			Effective November 1, 2023 ($)			Increase ($ / %)
Mr. Little		$	1,100,000		$	1,100,000	$0
Mr. Sullivan		$	750,000		$	800,000	$50,000 (6.7%)
Mr. O’Toole		$	600,000		$	650,000	$50,000 (8.3%)
Ms. Langley		$	460,000		$	500,000	$40,000 (8.7%)
Mr. Hill		$	465,000		$	478,950	$13,950 (3.0%)

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Short-Term Incentive Program — Annual Cash Bonus

Executive Officer Bonus Program

Annual cash bonuses to our NEOs are based on a percentage of the executive’s annual salary and adjusted based on performance as compared to metrics determined by the HC&CC. The annual bonus program for fiscal 2024 for those serving as executive officers at the start of fiscal 2024 (the “Executive Officer Bonus Program”) was designed to measure Company-wide performance against three metrics:

•

Adjusted EBITDA (40% of the bonus target);

•

Adjusted Net Sales (40% of the bonus target); and

•

Strategic Priorities (20% of the bonus target),

The metrics and targets for the Executive Officer Bonus Program were chosen based on fulfilling our Company’s business plan for fiscal 2024 and to ensure alignment with shareholder interests. We chose Adjusted EBITDA to emphasize profit growth and Adjusted Net Sales to emphasize top line growth. We selected Strategic Priorities in order to emphasize a tight alignment by our executives around a clear set of enterprise priorities that have a meaningful impact on the business.

The performance goals for each metric were set by the HC&CC at the beginning of fiscal 2024. The HC&CC assigned individual bonus targets to each of the executive officers, based upon individual performance and peer group market data provided by Meridian. The following bonus targets, defined as a percentage of the individual’s base salary for the term of the bonus program, were assigned to the following individuals at the HC&CC’s November 2023 meeting:

Name	Bonus Target as a Percentage of Base Salary
Mr. Little		125%
Mr. Sullivan		75%
Mr. O’Toole		75%
Ms. Langley		70%
Mr. Hill		65%

Our NEOs are eligible to receive bonus payouts under the Executive Officer Bonus Program upon achievement of results compared against pre-determined Company performance targets established by the HC&CC.

For the Executive Officer Bonus Program for fiscal 2024, the combined weighted payout for these named executive officers was 97% of the target amount, based on outcomes under the following three performance metrics:

% of
Bonus

Performance Range

Award
Percentage
Payout

Threshold

Target

Stretch

FY24 Actual
Performance
Achievement

Adjusted EBITDA

40%

$328 million
(96% of target
performance)

$340 million

$380 million
(112% of target
performance)

$353 million
(104% of target
performance)

141%

Adjusted Net Sales

40%

$2,238 million
(97% of target
performance)

$2,305 million

$2,486 million
(108% of target
performance)

$2,241 million
(97% of target
performance)

52%

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

	% of Bonus	Performance Range
	% of Bonus	Priority	Weighting	FY24 Actual Performance Achievement	Award Percentage Payout
Strategic Priorities	20%	Optimization of Wet Shave Supply Chain	35%	100%	100%
		Improvement of Innovation Capability	35%	100%
		Integrated Business Planning (IBP)	15%	100%
		Effective Cashflow Management	15%	100%
TOTAL	100%				97% of Target

Bonus payouts increase relative to final results between the goals indicated with maximum bonus at stretch. No bonuses are paid for results below the threshold goal. The threshold for Adjusted EBITDA and Adjusted Net Sales is 50%. The maximum payout for the financial goals (Adjusted EBITDA and Adjusted Net Sales) is 225% and the maximum payout for strategic priorities is 100%. Thus, the total bonus payout is capped at 200% for Company performance at, or above, the stretch goal.

The Company uses non-GAAP information internally to make operating decisions and believes it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded.

The Company utilizes “adjusted” non-GAAP measures including gross profit, selling general and administrative (“SG&A”), operating income, income taxes, net earnings, diluted earnings per share, and EBITDA to make internal operating decisions. The following items are excluded when analyzing non-GAAP measures: restructuring and related costs, acquisition and integration costs, Sidney fire costs, legal projects and settlements, regulatory projects, investment income (expense), debt retirement fees, and, at times, management excludes other costs and income.

Adjusted EBITDA

Adjusted EBITDA means our Company’s EBITDA determined in accordance with U.S. generally accepted accounting principles (“GAAP”), subject to adjustment for certain limited matters, including the effects of acquisitions, divestitures, extraordinary transactions such as mergers or spin-offs, reorganizations, unusual or non-recurring non-cash accounting impacts, and costs associated with restructurings.

The HC&CC determined that, for purposes of the plan, Adjusted EBITDA for the period was $353 million, resulting in awards payable under the plan at 141% of target with respect to this performance metric.

Adjusted Net Sales

Adjusted Net Sales means net sales, as determined in accordance with GAAP, adjusted to account for the impact of changes in foreign currency, the impact of acquisitions and divestitures, extraordinary transactions such as mergers or spin-offs, reorganizations, and unusual or non-recurring non-cash accounting impacts, and costs associated with restructurings.

The HC&CC determined Adjusted Net Sales for the period was $2,241 million, resulting in awards payable under the plan at 52% of target with respect to this performance metric.

Strategic Priorities

Strategic Priorities are a set of four enterprise-wide strategic objectives selected each fiscal year and designed to promote a “one team mindset” by aligning the Company’s executive officers around a clear set of enterprise priorities and critical shared goals. The HC&CC determined that the Company had achieved 100% of the Strategic Priorities for the performance period, resulting in awards payable under the plan at 100% of target with respect to this performance metric.

See “Executive Compensation — Summary Compensation Table” for the payouts under the Executive Bonus Program for fiscal 2024 for each of the NEOs. See “Appendix A — Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures used herein to their most directly comparable GAAP measures.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Historical Pay-for-Performance Table

In keeping with the Company’s policy of pay-for-performance, the following table sets forth the bonus target percentages approved for each NEO for the prior three years along with the potential bonus amount and the actual bonus paid.

Name and Principal Position	Year		Salary			Bonus Target Percentage		Bonus Available at Target			Bonus Paid
Rod R. Little President and Chief Executive Officer		2024		$	1,100,000		125%		$	1,375,000		$	1,338,563
		2023		$	1,100,000		125%		$	1,375,000		$	1,727,770
		2022		$	1,050,000		115%		$	1,207,500		$	1,017,923
Daniel J. Sullivan Chief Financial Officer and Chief Operating Officer		2024		$	800,000		75%		$	600,000		$	584,100
		2023		$	750,000		75%		$	562,500		$	706,680
		2022		$	730,000		75%		$	547,500		$	424,619
Eric F. O’Toole Former President, North America		2024		$	650,000		75%		$	487,500		$	474,582
		2023		$	600,000		75%		$	450,000		$	565,344
		2022		$	520,000		70%		$	364,000		$	282,304
LaTanya Langley Chief People Officer, Chief Legal Officer and Secretary		2024		$	500,000		70%		$	325,000		$	340,725
John N. Hill Former Chief Human Resources Officer		2024		$	478,950		65%		$	311,317	$0 (1)
		2023		$	465,000		65%		$	302,250		$	379,723
		2022		$	445,000		60%		$	267,000		$	207,075

(1) Mr. Hill retired on January 5, 2024. As a result, no bonus was paid.

Long-Term Incentive Program — Equity Awards (Restricted Stock Equivalents and Options)

Our 2nd A&R 2018 Plan authorizes the HC&CC to grant various types of equity awards. Under the 2nd A&R 2018 Plan, the HC&CC granted RSE awards, consisting of PRSEs and time-vesting awards to key executives. PRSE awards are tied to both the achievement of Company performance targets over a set time period (typically three years) and continued employment with our Company over the same period as conditions to vesting of the awards. Time-vesting RSE awards are tied solely to continued employment with our Company over a set time period as the condition to vesting of the awards. The HC&CC also granted key executives’ stock option awards under the 2nd A&R 2018 Plan, tied to continued employment with our Company over a set time period as the condition to vesting of the awards.

Timing and Procedures for Grants

Other than in exceptional cases, such as promotions or new hires, long-term incentive awards are generally granted in the first quarter of the fiscal year (October through December), at the time when salary levels and short-term incentive programs for the new fiscal year are determined.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Our CEO recommends to the HC&CC the number and type of RSEs and stock options to be awarded to each NEO (other than our CEO). The HC&CC considers the equity awards for executive officers based in part upon benchmarked data from our peer group provided by Meridian valued on the date of grant, as well as other factors, such as the officers’ individual performance, current dilution rates, and the market run-rate for equity grants among the peer group.

With respect to awards to our CEO, Meridian, without input from our CEO or other members of management, provides a competitive market analysis to the HC&CC based on the benchmarking peer group. The HC&CC determines the award to recommend to our Board considering the market analysis, performance of our Company, returns to shareholders, and experience and effectiveness of our CEO’s leadership, as well as the input from Meridian.

The RSE awards are stock settled at the time of vesting when they convert into unrestricted shares of our common stock. PRSE awards are earned based on the level of performance over the vesting period against pre-established goals. Upon vesting, stock option awards become exercisable for the purchase of shares of our common stock at a price per share established at the time of grant, so that the option will have no financial value unless the price of our common stock appreciates following the date of grant. The value of all our equity awards fluctuates based on performance of our Company’s common stock over time. This combination of financial performance and stock price performance enhances alignment with our shareholders.

Restricted Stock Equivalent Award Grants during Fiscal 2024

The HC&CC approved the grant of both performance-based and time-vesting RSE awards to our NEOs in November 2023. The number and type of RSE awards granted to each NEO is shown in the “Grants of Plan-Based Awards” table.

For the PRSEs granted in November 2023, we used a three-year relative TSR metric, benchmarked against a custom group consisting of the S&P 1000 Consumer Staples Sector and certain non-overlapping executive compensation benchmarking peers in order to provide a relative performance metric and tie our executive leadership’s performance outcome to our stock performance. The HC&CC annually reviews the peer set to ensure the correct peer set is used and that the Company’s long-term incentive plan delivers the expected pay outcomes relative to the expectations of our executives and shareholders. The HC&CC believes the following select group of peer companies provides a more robust sample size and a greater representation than using the executive compensation benchmarking peer group for purposes of the Company’s long-term incentive plan.

■ Andersons, Inc.	■ Fresh Del Monte Produce, Inc.	■ Prestige Consumer Healthcare, Inc.
■ B&G Foods, Inc.	■ Grocery Outlet Holding Corp.	■ PriceSmart, Inc.
■ BellRing Brands, Inc.	■ Hain Celestial Group, Inc.	■ Seneca Foods Corporation
■ BJ’s Wholesale Club Holdings, Inc.	■ HanesBrands Inc.	■ Simply Good Foods Company
■ Boston Beer Company, Inc.	■ Hasbro, Inc.	■ Sleep Number Corporation
■ Calavo Growers, Inc.	■ Helen of Troy Limited	■ SpartanNash Company
■ Cal-Maine Foods, Inc.	■ Hostess Brands, Inc.	■ Spectrum Brands Holdings, Inc.
■ Casey’s General Stores, Inc.	■ Ingredion Incorporated	■ Sprouts Farmers Market, Inc.
■ Celsius Holdings, Inc.	■ Inter Parfums, Inc.	■ Tootsie Roll Industries, Inc.
■ Central Garden & Pet Co.	■ J&J Snack Foods Corp.	■ TreeHouse Foods, Inc.
■ Chef’s Warehouse, Inc.	■ John B. Sanfilippo & Son, Inc.	■ Tupperware Brands Corporation
■ Church & Dwight Co., Inc.	■ Lancaster Colony Corp.	■ United Natural Foods, Inc.
■ Clorox Company	■ Medifast, Inc.	■ Universal Corporation
■ Coca-Cola Consolidated, Inc.	■ MGP Ingredients, Inc.	■ U.S. Foods Holding Corp.
■ Coty, Inc.	■ National Beverage Corp.	■ USANA Health Sciences, Inc.
■ Darling Ingredients, Inc.	■ Nu Skin Enterprises, Inc.	■ Vector Group Ltd.
■ e.l.f. Beauty, Inc.	■ Oxford Industries, Inc.	■ WD-40 Company
■ Energizer Holdings, Inc.	■ Performance Food Group Co.
■ Flowers Foods, Inc.	■ Pilgrim’s Pride Corporation
■ Fossil Group, Inc.	■ Post Holdings, Inc.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

The PRSEs will vest and convert into shares of Edgewell common stock on a date chosen by the Board shortly after their certification of the Company’s earnings for the fiscal year ending September 30, 2026 if the relative TSR metric for the three-year period commencing October 1, 2023 through September 30, 2026 (the “Performance Period”) equals or exceeds the hurdles set forth below relative to our peer group and subject to the recipient remaining employed with our Company on the vesting date.

Percentile
Ranking

Payout
(% of Target)

Below Threshold

<25th

Threshold

25th

50%

Target

50th

100%

Max or Above

75th

200%

The PRSEs have a threshold, target and stretch level of performance. Upon achievement of the threshold level of performance, 50% of the stock equivalents will vest; 100% will vest upon achievement of target level performance; and 200% will vest upon achievement of stretch level performance. No PRSEs will vest if results are below the threshold goal, and no additional awards will vest if results are above the stretch goal. Vesting will increase proportionately in 1/10th of 1% increments for final results between the goals indicated.

The time-vesting RSE awards vest in equal installments on each of the first three anniversaries of the date of grant if the recipient remains employed with our Company on the vesting date.

Stock Option Award Grants during Fiscal 2024

The HC&CC approved the grant of stock option awards to the NEOs in November 2023. The stock option awards vest in equal installments on each of the first three anniversaries of the grant date if the recipient remains employed with our Company. Each option has an exercise price equal to the closing market price of our common stock on the date of grant, which was $34.22. These options will have value only if our Company’s stock price increases above $34.22, which provides an incentive for the NEOs to increase shareholder value, thereby aligning their interests with those of our Company’s shareholders. The number of options granted to each NEO is shown in the “Grants of Plan-Based Awards” table.

Retirement Plans

Prior to January 1, 2014, our defined benefit pension plan covered essentially all U.S. employees after one year of service. As a qualified plan, it was subject to maximum pay and benefit limits under applicable U.S. tax rules. Our SERP provided a supplement to an executive’s pension benefit equal to the amount that the executive would have received but for the tax limitations. Details of benefits under the defined benefit plan and the SERP are set forth in the “Pension Benefits Table,” including the accompanying narrative. Effective January 1, 2014, the pension benefit earned to date by active participants under our Company’s legacy U.S. defined benefit pension plan was frozen and future accruals are no longer provided. When the pension plan was frozen, the SERP was similarly frozen.

Our NEOs are covered by our qualified defined contribution 401(k) plan and entitled to a Company match on a portion of their deferrals to the plan. The elimination of the U.S defined benefit pension plan described above was partially offset by an increase in our Company match to contributions made by participants into our defined contribution 401(k) and ESIP. The amounts which may be deferred on a tax preferred basis into the qualified plan, as well as the amount of the matching contributions, are also subject to IRS limitations. We have also established supplemental plans to compensate executives for these limits. Our ESIP permits executives to defer any excess contributions and matching payments not permitted into the qualified 401(k) plan. According to market data provided by Meridian, these types of benefits are generally offered by our peer group, often with enhanced benefit formulas (which we do not provide). Details of the ESIP, including the contributions, earnings, and year-end balances, are set forth in the “Non-qualified Deferred Compensation Table.”

Severance and Other Benefits Following a Change in Control

The HC&CC has adopted a CIC Plan in which current and future executive officers, including the NEOs, will be eligible to participate, as discussed under “Potential Payments upon Termination or Change in Control.” Please refer to that section for more information.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Perquisites

We offer a limited number of perquisites for our executive officers. The perquisites or executive benefits consist of the executive financial planning program, group life insurance, accidental death and dismemberment insurance, and an executive long-term disability plan. We regularly review the benefits provided to our executives and make appropriate modifications based on peer group analysis and the HC&CC’s evaluation of the retentive value of these benefits.

Executive Officer Stock Ownership Requirements

To directly align the interests of our NEOs with our shareholders, our stock ownership guidelines provide that the CEO maintain ownership of our common stock with a value of at least five times his base salary, and other executive officers must maintain common stock ownership with a value of at least three times their base salaries. New executive officers are given a period of five years to attain full compliance with the guidelines.

Group			Ownership Level
CEO			5X base salary
Other NEOs			3X base salary

For purposes of this determination, stock ownership includes shares of our common stock which are owned directly or by family members residing with the executive or by family trusts, vested and deferred RSEs, unvested RSEs (other than equivalents subject to achievement of performance targets), and common stock or stock equivalents credited to an officer under our defined contribution 401(k) plan, our ESIP, or our deferred compensation plan. As of September 30, 2024, each of our NEOs with five years or more of service were in compliance with these guidelines.

Excessive Risk-Taking Mitigation

Anti-Hedging Policy

Under our insider trading policy, directors, officers and employees or their designees are prohibited from engaging in speculative trading or hedging transactions in Edgewell securities or purchasing any financial instruments or entering into any other arrangements designed to hedge or offset any decrease in the market value of Edgewell securities, including prohibitions on:

•

investing or trading in market-traded options on Edgewell securities — i.e., puts and calls;

•

purchasing financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds) that are designed to profit from, hedge or offset any change in the market value of equity securities (1) granted by our Company to the director, officer or employee as part of the compensation of the employee or member of our Board; or (2) held, directly or indirectly, by the director, officer or employee;

•

engaging in “short-sales” of Edgewell securities — i.e., selling Edgewell stock not owned at the time of the sale;

•

entering into a “sale against the box” transaction (loaning Edgewell stock to another individual and receiving cash back as security for the loan); or

•

speculating on relatively short-term price movements of Edgewell securities — i.e., engaging in a purchase and sale of Edgewell stock within a short period of time.

Our policy prohibits directors, officers and employees from purchasing Edgewell securities on margin, holding Edgewell securities in a margin account, or pledging Edgewell securities as collateral. The policy also prohibits engaging in any other transaction involving Edgewell securities that suggests the misuse of information that is unavailable to the general public.

Incentive Compensation Recoupment Policy

On September 13, 2023, the HC&CC adopted the Edgewell Personal Care Company Incentive Compensation Recoupment Policy (the “Recoupment Policy”) replacing the previous Incentive Compensation Recoupment Policy dated April 24, 2017. Under the Recoupment Policy, our Board, through the HC&CC, may direct our Company to recover reasonably promptly the amount of erroneously awarded compensation in the event that the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

“Incentive-based compensation” under the Recoupment Policy means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a financial reporting measure. “Erroneously awarded compensation” means the amount of incentive-based compensation received that exceeds the amount of incentive-based compensation that otherwise would have been received had it been determined based on the restated amounts and shall be computed without regard to any taxes paid. For incentive-based compensation based on stock price or total shareholder return, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in an accounting restatement, the amount shall be based on a reasonable estimate of the effect of the accounting restatement on the stock price or total shareholder return upon which the incentive-based compensation was received.

The Recoupment Policy applies to all incentive compensation, granted, paid or credited after October 2, 2023 and applies to all incentive-based compensation received by a person who served as an executive officer at any time during the performance period for that incentive-based compensation, including any transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years. Our Board and the HC&CC may instruct our Company to recover and/or cancel any overpayment made at any time through the end of the third fiscal year following the year for which inaccurate performance criteria were measured. If steps have been taken within this period to restate our Company’s results, the time period shall be extended until the restatement is completed.

Executive Severance Plan

The HC&CC does not believe employment contracts for executives are necessary because our executives have developed a focus on the Company’s long-term success. On September 23, 2016, the HC&CC adopted an executive severance plan (the “Executive Severance Plan”) for our Company to govern situations in which an executive’s employment with the Company is terminated, other than for cause. The Severance Plan provides benefits to a number of our Company’s executives, including the NEOs, in the event of a qualifying termination, which includes an involuntary termination without cause or a voluntary termination as a result of good reason (as such terms are defined in the plan). In adopting the Severance Plan, the HC&CC considered that the market practice at peer companies is to provide executives with certain benefits in the event of such terminations, and therefore concluded that the plan would be a significant benefit to our Company in attracting and retaining key executives by offering a competitive total compensation package.

Post-termination benefits for participating executives consist of a lump sum payment equal to:

•

the executive’s annual base salary plus a severance bonus equal to the target short-term incentive plan target bonus for the executive for the most recently completed fiscal year, except in the case of the CEO, where such payment will be equal to two times for the CEO and 1.5 times for the NEOs the sum of the annual base salary and target severance bonus; and

•

1.5 times the monthly premium cost for group health plan benefits for the NEO multiplied by 18, except in the case of the CEO where the health costs will be multiplied by 24.

Such benefits are subject to reduction under certain circumstances, including to the extent necessary to avoid certain federal excise taxes. In addition, no benefits will be paid to the extent duplicative of benefits under a change in control or similar agreement with our Company.

The payment of benefits under the Severance Plan is conditioned upon, among other things, the executive executing a general release in favor of our Company, which shall include confidentiality, non-solicitation, non-disparagement and non-competition obligations of the employee in favor of our Company.

A description of the projected cost, if all of the NEOs were terminated on September 30, 2024, is provided under “Potential Payments upon Termination or Change in Control.”

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

SUMMARY COMPENSATION TABLE

This Summary Compensation Table sets forth information for compensation relating to fiscal years 2024, 2023 and 2022. For a discussion of fiscal 2024 compensation, see “Compensation Discussion and Analysis” above.

Name and Principal Position	Year		Salary			Bonus (1)			Stock Awards (2)			Option Awards (3)			Non- Equity Incentive Plan Compensation (1)			Change in Pension Value and Non- qualified Deferred Compensation Earnings (4)			All Other Compensation (5)			Total
Rod R. Little President and Chief Executive Officer		2024		$	1,100,000		$	0		$	6,267,970		$	1,200,003		$	1,338,563	$0				$	172,377		$	10,078,913
		2023		$	1,095,833		$	0		$	6,360,768		$	1,200,006		$	1,727,440	$0				$	133,081		$	10,157,128
		2022		$	1,045,833		$	0		$	6,012,124		$	1,100,002		$	1,017,923	$0				$	144,398		$	9,320,280
Daniel J. Sullivan Chief Financial Officer and Chief Operating Officer		2024		$	795,834		$	0		$	1,360,174		$	280,007		$	584,100	$0				$	20,293		$	3,040,408
		2023		$	748,334		$	0		$	1,451,162		$	280,002		$	706,680	$0				$	19,785		$	3,205,963
		2022		$	728,333		$	0		$	1,279,859		$	240,013		$	424,619	$0				$	76,354		$	2,749,178
Eric F. O’Toole Former President, North America		2024		$	645,834		$	0		$	1,068,732		$	220,007		$	474,582	$0				$	71,627		$	2,480,782
		2023		$	593,334		$	0		$	1,036,533		$	200,006		$	565,344	$0				$	50,689		$	2,445,906
		2022		$	518,333		$	0		$	799,898		$	150,001		$	282,304	$0				$	18,606		$	1,769,142
LaTanya Langley Chief People Officer, Chief Legal Officer and Secretary		2024		$	496,667		$	0		$	777,291		$	160,008		$	340,725	$0				$	54,126		$	1,828,817
John N. Hill Former Chief Human Resources Officer		2024		$	127,646		$	0	$0			$0			$0				$	232,568		$	2,147,807(6)		$	2,514,283
																			$	6,262
		2023		$	463,334		$	0		$	673,777		$	130,009		$	379,723		$	189,648		$	46,929		$	1,896,535
																			$	13,115
		2022		$	443,750		$	0		$	693,252		$	130,014		$	207,075		$	114,917		$	57,611		$	1,623,822
																			$	(22,797)

(1)

All awards under our Executive Officer Bonus Program are based upon achievement of Company performance measures established at the beginning of a performance period. Consequently, the value of all bonuses earned during the fiscal year under these programs has been included in the Non-Equity Incentive Plan Compensation column of this table. See “Compensation Discussion and Analysis — Elements of Compensation — Incentive Programs — Short-Term Incentive Program — Annual Cash Bonus.”

(2)

The amounts listed in this column include both time-vesting and performance-based restricted stock equivalent grants awarded in fiscal 2024 to our named executive officers. The value of the performance-based award is calculated in accordance with the Financial Accounting Standard Board’s (“FASB”) ASC Section 718. Our Company records estimated expense for performance-based grants based on target achievement of performance metrics for the three-year period, unless evidence exists that achievement above or below target for the applicable performance metric is more likely to occur. The following is the maximum value, if paid, for the performance award granted in fiscal 2024, based on the grant date value: Mr. Little, $7,100,034; Mr. Sullivan, $1,400,009; Mr. O’Toole, $1,100,002; Ms. Langley, $800,029. Mr. Hill did not receive an award due to his planned retirement.

(3)

The amounts listed in this column reflect the aggregate grant date fair value of stock options granted to our named executive officers calculated in accordance with FASB ASC Section 718, and do not reflect actual amounts paid to them, or realized by them, or that may be realized upon exercise by them. Assumptions used in the calculation of these amounts are included in “Note 15. Share-Based Payments” of the Notes to Consolidated Financial Statements of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

(4)

The amount reported in this column with respect to fiscal 2024 consists of the following:

Name	Change in Pension Value (i)			Above-market Earnings on Non-Qualified Deferred Compensation			Total
Mr. Little	$0			$0			$0
Mr. Sullivan	$0			$0			$0
Mr. O’Toole	$0			$0			$0
Ms. Langley	$0			$0			$0
Mr. Hill		$	10,542		$	222,026		$	232,568
		$	6,262 (ii)	$0				$	6,262

(i)

Unless otherwise noted, these amounts reflect the aggregate changes in the actuarial present value of accumulated benefits under our defined benefit pension plan and the SERP, which are described in the narrative to the “Pension Benefits Table.” For the final average earnings formula benefit under the defined benefit pension plan, this amount reflects the difference in the calculated present value of the benefit during fiscal 2024. To the extent that payments under the defined benefit pension plan exceed limitations imposed by the U.S. Internal Revenue Service, the excess will be paid under the terms of the SERP. This also includes above-market earnings on non-qualified deferred compensation in our deferred compensation plan.

(ii)

This amount reflects Mr. Hill’s participation in the Pension Plan for Employees of Edgewell Personal Care, which was a frozen plan in Canada. The plan was wound up and sold to an annuity insurance company on March 31, 2023. The amount for Mr. Hill was converted from Canadian dollars into U.S. dollars at the exchange rate of 1 CAD equals 0.7395 USD, the exchange rate in effect on September 30, 2024.

(5)

The amounts reported in this column with respect to fiscal 2024 consist of the following:

Name	Company Matching Contributions 401(k) Plan (i)			Company Matching Contributions ESIP (i)			Term Life Insurance Premiums (ii)			Executive Financial Planning Program (iii)			HSA Employer Contribution (iv)			Wellness Credit (v)			AD&D and LTD Insurance Premiums (vi)			Total
Mr. Little		$	20,700		$	149,846		$	102	$0				$	1,500		$	25		$	204		$	172,377
Mr. Sullivan		$	18,487	$0				$	102	$0				$	1,500	$0				$	204		$	20,293
Mr. O’Toole		$	20,700		$	50,621		$	102	$0			$0			$0				$	204		$	71,627
Ms. Langley		$	21,330		$	30,738		$	102		$	1,752	$0			$0				$	204		$	54,126
Mr. Hill		$	6,554		$	31,023		$	30	$0			$0			$0				$	59		$	37,666 (6)

(i)

Company matching contributions or accruals in our 401(k) plan and ESIP.

(ii)

Term life insurance premiums paid by our Company for the first $50,000 coverage for each of the NEOs.

(iii)

We reimburse the executives for 80% of the cost of personal financial advisory services, up to certain annual maximums.

(iv)

Our Company pays an annual contribution to a Health Savings Account for each executive who elects to participate.

(v)

Our Company pays an annual wellness credit for each executive who completes a biometric screening and health survey.

(vi)

Our Company pays the premiums for Group Accidental Death & Dismemberment ($12.00 per person) and Group Long-Term Disability ($192 per person).

(6)

As a result of his retirement, the amount reported in this column reflects the additional compensation Mr. Hill received of $1,319,442 severance; $362,605 deferred compensation pay; $155,040 SERP payout; and $273,055 EPC defined benefit plan payout.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

The above list of perquisites does not include any contributions made by our charitable trust which may have been made at the request of any of the NEOs. The trustees of that trust, who are employees of our Company, review requests for contributions to charitable organizations from employees, officers, directors, and the community at large, and, in their sole discretion, authorize contributions in accordance with the purposes of the trust. Officers are also eligible to participate in the charitable trust matching gift program, which is generally available to U.S. employees. Under this program, the foundation matches 100% of charitable donations of a minimum of $25 made to eligible charities, up to a maximum of $5,000 per year for each individual. Our Company will continue to honor requests under the charitable trust guidelines as long as funds exist at an appropriate level to do so.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

GRANTS OF PLAN-BASED AWARDS

Awards to the NEOs, and to other key executives, were made in fiscal 2024 under two separate plans or programs:

•

Our short-term incentive program, pursuant to which potential cash awards were granted, dependent upon achievement of Company performance measures established at the beginning of the term of the program, as described in more detail in “Compensation Discussion and Analysis — Elements of Compensation — Incentive Programs — Short-Term Incentive Program — Annual Cash Bonus,” and

•

Our long-term incentive program, pursuant to which RSE awards (performance-based and time-vesting) and stock option awards were granted under the terms of our 2nd A&R 2018 Plan as described in more detail in “Compensation Discussion and Analysis — Elements of Compensation — Long-Term Incentive Programs — Equity Awards (Restricted Stock Equivalents and Options).”

GRANTS OF PLAN-BASED AWARDS TABLE

Name	Type of Award	Meeting Date		Grant Date		Estimated Future Payouts Under Non-Equity Incentive Plan Awards									Estimated Future Payouts Under Equity Incentive Plan Awards (#)						All Other Stock Awards: Number of Shares of Stock (#)		All Other Option Awards: Number of Shares Underlying Options (#)		Exercise or Base Price of Option Awards ($/Sh)			Grant Date Fair Value Of Stock And Option Awards (1)
Name	Type of Award	Meeting Date		Grant Date		Threshold			Target			Maximum			Threshold		Target		Maximum		All Other Stock Awards: Number of Shares of Stock (#)				Exercise or Base Price of Option Awards ($/Sh)			Grant Date Fair Value Of Stock And Option Awards (1)
Mr. Little	Bonus: Annl. Perf. (2)						$	687,500		$	1,375,000		$	2,750,000
	Perf Awd: RSE (3)		11/1/2023		11/10/2023																	43,835							$	1,500,034
	Perf Awd: PRSE (4)		11/1/2023		11/10/2023											51,871		103,741		207,482									$	4,767,936
	Perf Awd: Options (5)		11/1/2023		11/10/2023																			89,021		$	34.22		$	1,200,003
Mr. Sullivan	Bonus: Annl. Perf. (2)						$	300,000		$	600,000		$	1,200,000
	Perf.Awd: RSE (3)		11/1/2023		11/10/2023																	12,274							$	420,016
	Perf.Awd: PRSE (4)		11/1/2023		11/10/2023											10,228		20,456		40,912									$	940,158
	Perf.Awd: Options (5)		11/1/2023		11/10/2023																			20,772		$	34.22		$	280,007
Mr. O’Toole	Bonus: Annl. Perf. (2)						$	243,750		$	487,500		$	975,000
	Perf Awd: RSE (3)		11/1/2023		11/10/2023																	9,644							$	330,018
	Perf Awd: PRSE (4)		11/1/2023		11/10/2023											8,037		16,073		32,146									$	738,715
	Perf Awd: Options (5)		11/1/2023		11/10/2023																			16,321		$	34.22		$	220,007
Ms. Langley	Bonus: Annl. Perf. (2)						$	175,000		$	350,000		$	700,000
	Perf Awd: RSE (3)		11/1/2023		11/10/2023																	7,014							$	240,019
	Perf Awd: PRSE (4)		11/1/2023		11/10/2023											5,845		11,690		23,380									$	537,272
	Perf Awd: Options (5)		11/1/2023		11/10/2023																			11,870		$	34.22		$	160,008
Mr. Hill	Bonus: Annl. Perf. (2)						$	155,659		$	311,318		$	622,635
	Perf Awd: RSE (3)		11/1/2023		11/10/2023																								$	0
	Perf Awd: PRSE (4)		11/1/2023		11/10/2023																								$	0
	Perf Awd: Options (5)		11/1/2023		11/10/2023																								$	0

(1)

This represents the grant date fair value calculated in accordance with FASB ASC Section 718, excluding forfeiture assumptions. For time-vesting awards, the value includes 100% of such awards, with no reduction for potential forfeiture.

(2)

These represent the amounts which potentially could have been earned under the fiscal 2024 Executive Officer Bonus Program.

(3)

These restricted stock equivalents (time-vested) awarded on November 10, 2023, will vest in three equal installments on each of the first three anniversaries of the date of grant if the officer remains employed with us at that time. The value of the amount calculated in accordance with accounting guidance is included in the “Stock Awards” column of the “Summary Compensation Table.”

(4)

These restricted stock equivalents (performance-based) awarded on November 10, 2023, will vest upon certification by the Board and release of our earnings for the fiscal year ending September 30, 2026 if the officer remains employed with us at that time and if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance criteria for these awards is relative total shareholder return for the “Performance Period” beginning on October 1, 2023 (100%). The percentage of the PRSEs vesting will range from 0% to 200% based on

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

performance. The value of the amount calculated in accordance with accounting guidance is included in the “Stock Awards” column of the “Summary Compensation” table.

(5)

These stock options awarded on November 10, 2023 will vest in three equal installments on each of the first three anniversaries of the date of grant if the officer remains employed with us at that time. The value of the amount calculated in accordance with accounting guidance is included in the “Option Awards” column of the “Summary Compensation” table. The exercise price of $34.22 per share reflects the closing market price of our common stock on the date of grant.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END

The following types of equity awards have been granted to the NEOs, and remain unvested, or, in the case of non-qualified stock options, unvested or unexercised, as of September 30, 2024.

•

RSEs that vest over a period of time and at vesting convert into non-restricted shares of our common stock. As of September 30, 2024, we had outstanding unvested RSE awards with initial vesting terms of equal installments on each of the first three anniversaries of the grant date. Unvested RSE awards are included under “Stock Awards — Number of Shares or Units of Stock That Have Not Vested,” in the table below.

•

RSEs that vest subject to the achievement of performance-based conditions and at vesting convert into non-restricted shares of our common stock. As of September 30, 2024, we had outstanding unvested RSE awards with performance-based vesting conditions that will vest on a date chosen by the Board shortly after their certification once our Company releases earnings for the fiscal year ending September 30, 2024, subject to satisfaction of specific performance criteria being met. In addition, we had outstanding unvested restricted stock equivalent awards with performance-based vesting conditions that will vest on a date chosen by the Board shortly after their certification once our Company releases earnings for the fiscal year ending September 30, 2025, subject to satisfaction of specific performance criteria being met. The performance metrics are Relative Total Shareholder Return (100%). The percentage of the PRSEs vesting will range from 0% to 200% based on performance. We also had outstanding unvested restricted stock equivalent awards with performance-based vesting conditions that will vest on a date chosen by the Board shortly after their certification once our Company releases earnings for the fiscal year ending September 30, 2026, subject to satisfaction of specific performance criteria being met. The performance metrics are Relative Total Shareholder Return (100%). The percentage of the PRSEs vesting will range from 0% to 200% based on performance. Unvested awards are included under “Stock Awards — Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested” in the table below.

•

Non-qualified stock options granting the right to acquire shares of our common stock at an exercise price equal to the closing price of our common stock on the grant date. These options become exercisable in equal installments on each of the first three anniversaries of the grant date and remain exercisable over the ten-year period following grant. Outstanding option awards are described under “Option Awards,” in the table below.

RSEs and non-qualified stock options were granted under the terms of our 2nd A&R 2018 Plan.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END TABLE

Name	Option Awards									Stock Awards
Name	Number of Securities Underlying Unexercised Options (#) Exercisable		Number of Securities Underlying Unexercised Options (#) Unexercisable		Option Exercise Price ($)			Option Expiration Date		Number of Shares or Units of Stock That Have Not Vested (#)		Market Value of Shares or Units of Stock That Have Not Vested ($) (1)			Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)		Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) (1)
Mr. Little		15,421		0 (2)		$	42.71		11/15/2028		10,587 (10)		$	384,732		139,756 (13)		$	5,078,733
		18,561		0 (3)			44.74		3/1/2029		25,157 (11)			914,205		166,038 (14)			6,033,821
		96,464		0 (4)			31.44		11/14/2029		43,835 (12)			1,592,964		207,482 (15)			7,539,896
		81,719		0 (5)			38.91		11/13/2030
		39,050		0 (6)			35.37		11/13/2030
		50,194		25,097 (7)			43.29		11/12/2031
		26,282		52,562 (8)			39.75		11/11/2032
		0		89,021 (9)			34.22		11/10/2033
Mr. Sullivan		23,580		0 (4)		$	31.44		11/14/2029		2,772 (10)		$	100,734		27,721 (13)		$	1,007,381
		18,535		0 (5)			38.91		11/13/2030		7,044 (11)			255,979		35,221 (14)			1,279,931
		8,857		0 (6)			35.37		11/13/2030		12,274 (12)			446,037		40,912 (15)			1,486,742
		10,952		5,476 (7)			43.29		11/12/2031
		6,133		12,264 (8)			39.75		11/11/2032
		0		20,772 (9)			34.22		11/10/2033
Mr. O’Toole		11,795		0 (5)		$	38.91		11/13/2030		1,732 (10)		$	62,941		17,326 (13)		$	629,627
		5,637		0 (6)			35.37		11/13/2030		5,032 (11)			182,863		25,158 (14)			914,242
		6,844		3,422 (7)			43.29		11/12/2031		9,644 (12)			350,463		32,145 (15)			1,168,149
		4,381		8,760 (8)			39.75		11/11/2032
		0		16,321 (9)			34.22		11/10/2033
Ms. Langley		3,354		1,677 (16)		$	36.77		4/1/2032		3,270 (11)		$	118,832		8,839 (18)		$	321,209
		2,848		5,694 (8)			39.75		11/11/2032		7,014 (12)			254,889		16,353 (14)			594,268
		0		11,870 (9)			34.22		11/10/2033		884 (17)			32,125		23,379 (15)			849,593
Mr. Hill (19)		17,379		0		$	100.68		7/6/2025
		14,695		0			74.70		11/3/2026
		6,139		0			58.90		11/13/2027
		7,711		0			42.71		11/15/2028
		13,505		0			31.44		1/5/2029
		10,110		0			38.91		1/5/2029
		4,831		0			35.37		1/5/2029
		5,933		0			43.29		1/5/2029
		2,848		0			39.75		1/5/2029

(1)

Values based on the closing price of our Company’s common stock on the NYSE on September 30, 2024, the last trading day of the fiscal year, of $36.34.

(2)

Represents stock options granted on 11/15/2018 which are fully vested and exercisable.

(3)

Represents stock options granted on 3/1/2019 which are fully vested and exercisable.

(4)

Represents stock options granted on 11/14/2019 which are fully vested and exercisable.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

(5)

Represents premium stock options granted on 11/13/2020 which are fully vested and exercisable.

(6)

Represents stock options granted on 11/13/2020 which are fully vested and exercisable.

(7)

Represents stock options granted on 11/12/2021 which will vest on 11/12/2024. As of the date of this proxy, all of the options will be vested and exercisable.

(8)

Represents stock options granted on 11/11/2022 which will vest ratably on 11/11/2024 and 11/11/2025. As of the date of this proxy, two-thirds of the options will be vested and exercisable.

(9)

Represents stock options granted on 11/10/2023 which will vest ratably on 11/10/2024, 11/10/2025 and 11/10/2026. As of the date of this proxy, one-third of the options will be vested and exercisable.

(10)

Represents restricted stock equivalents granted on 11/12/2021 which will vest on 11/12/2024. As of the date of this proxy, this award will be fully vested.

(11)

Represents restricted stock equivalents granted on 11/11/2022 which will vest ratably on 11/11/2024 and 11/11/2025. As of the date of this proxy, two-thirds of this award will have vested.

(12)

Represents restricted stock equivalents granted on 11/10/2023 which will vest ratably on 11/10/2024, 11/10/2025 and 11/10/2026. As of the date of this proxy, one-third of this award will have vested.

(13)

Represents the maximum number of performance stock equivalents granted on 11/12/2021 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2024 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2021 and ending on September 30, 2024. As of the date of this proxy, the final four-quarter average payout that has vested equals 99.8% of the target.

(14)

Represents the maximum number of performance stock equivalents granted on 11/11/2022 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2025 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2022 and ending on September 30, 2025.

(15)

Represents the maximum number of performance stock equivalents granted on 11/10/2023 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2026 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2023 and ending on September 30, 2026.

(16)

Represents stock options granted on 4/1/2022 which will vest on 4/1/2025.

(17)

Represents restricted stock equivalents granted on 4/1/2022 which will vest on 11/12/2024. As of the date of this proxy, this award will be fully vested.

(18)

Represents the maximum number of performance stock equivalents granted on 4/1/2022 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2024 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2021 and ending on September 30, 2024. As of the date of this proxy, the final four-quarter average payout that has vested equals 99.8% of the target.

(19)

Due to Mr. Hill’s retirement, all of his vested stock options expire on their original expiration date or five years from his retirement date of 1/5/2024, whichever is earliest. The data in this table represents information from his Exit Form 4. The Company does not have access to updated information as he is no longer required to report to the SEC.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

OPTION EXERCISES AND STOCK VESTED

	Option Awards					Stock Awards
Name	Number of Shares Acquired on Exercise (#)		Value Realized on Exercise ($)			Number of Shares Acquired on Vesting (#) (1)		Value Realized on Vesting ($)
Mr. Little		0		$	0		123,724		$	4,222,700
Mr. Sullivan		0		$	0		29,101		$	993,217
Mr. O’Toole		0		$	0		18,763		$	640,381
Ms. Langley		0		$	0		7,279		$	266,041
Mr. Hill		0		$	0		15,579		$	531,711

(1)

In fiscal 2024, time-based RSEs and performance-based PRSEs granted to each of the officers in fiscal 2020, 2021 and 2022, vested in accordance with the terms of the awards. Upon vesting, the equivalents converted into shares of our common stock, which were then issued to the officers free of any restrictions.

PENSION BENEFITS

Prior to January 1, 2014, the Edgewell Defined Benefit Pension Plan covered essentially all U.S. employees after one year of service. As a qualified plan, it was subject to maximum pay and benefit limits under the tax rules. Our SERP provided a supplement to an executive’s pension benefit equal to the amount that the executive would have received but for the tax limitations. As of December 31, 2013, which was the end of the first quarter of fiscal 2014, the plans were frozen and future retirement service benefits are no longer accrued under these plans.

The Retirement Accumulation Account (“RAA”) that was effective from January 1, 2010 to December 31, 2013, included the future retirement benefits of the active participants in our defined benefit pension plan, including certain of the NEOs, which were determined in accordance with a retirement accumulation formula. The participants received monthly credits equal to 6% of their eligible benefit earnings for each month, which amounts were credited with monthly interest equal to the 30-year Treasury rate that was reset annually. As a transition for older/longer-tenured employees, who may have had less time to adjust their retirement planning, including the NEOs with age and years of service totaling at least 60 but not more than 74 as of December 31, 2009, such employees received an additional monthly credit equal to 2% of eligible benefit earnings for each month, and employees with age and years of service totaling 75 or more as of December 31, 2009 received an additional credit equal to 4% of their eligible benefit earnings for each month. These transition credits were available to eligible plan participants through 2013 (or, if earlier, their termination of employment with our Company).

The defined benefit pension plan has used other benefit calculation formulas, all of which have been frozen as of the end of calendar year 2009, such as:

•

Final Average Pay (“FAP”). The traditional FAP benefit provides 1.5% of five-year average “annual earnings” multiplied by a participant’s years of service (to a maximum of 40 years), reduced by a Social Security offset.

•

Pension Equity (“PEP”) benefit formula. Under PEP, an executive is entitled to a benefit (payable in lump sum or as a monthly annuity) based on five-year average annual earnings, which were multiplied by “pension equity credits” earned with years of service. The benefit was subject to a three-year vesting period. PEP was applied for the participating named executive officers.

•

PensionPlus Match Account (“PPMA”). The PPMA generally provided a 325% match under our defined benefit pension plan to those participants who made an after-tax contribution of 1% of their annual earnings to our 401(k) plan. To the extent an officer’s PPMA benefit was unavailable due to tax limits, the benefit was restored under our ESIP and not the SERP. The benefit was generally subject to a three-year vesting requirement. The PPMA benefit was eliminated for all employees as of the end of calendar year 2009.

The RAA, PEP and PPMA all continue to receive interest credits from January 1, 2010 to the date the benefits commence.

Mr. Hill participated in the defined benefit pension plan and the SERP but ceased earning additional accrued benefits under these plans when they were frozen as of January 1, 2014.

The Pension Plan for Employees of Edgewell Personal Care is a defined benefit type plan for certain of our employees in Canada similar to the Edgewell Defined Benefit Pension Plan for U.S. employees. Prior to July 1, 2015, this plan covered essentially all of our Canadian employees. As of July 1, 2015, this plan was frozen, and future benefits are no longer accrued under the plan. Mr. Hill participated in this plan but ceased earning additional accrued benefits under this plan when he transferred to the U.S. in August 2005.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

PENSION BENEFITS TABLE

Name	Plan Name	Number of Years Credited Service (#)		Present Value Of Accumulated Benefit ($) (1)			Payments During Last Fiscal Year ($)
Mr. Hill	Edgewell Personal Care Company Defined Benefit Plan							$	273,055
	Edgewell Personal Care Company SERP							$	155,040
	Pension Plan for Employees of Edgewell Personal Care (2)		1.58		$	35,212	$0

Note: Messrs. Little, Sullivan, O’Toole and Ms. Langley do not participate in these plans and, as such, are not included in the table.

(1)

Based on age, benefits are available without reduction. Assumptions utilized in the valuations are set forth in “Note 14. Retirement Plans” of the Notes to Consolidated Financial Statements of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

(2)

The amount shown for Mr. Hill reflects his participation in the Pension Plan for Employees of Edgewell Personal Care, which was a frozen plan in Canada. The plan was wound up and sold to an annuity insurance company on March 31, 2023. Amounts are converted from Canadian dollars into U.S. dollars at the exchange rate of 1 CAD equals 0.7395 USD, the exchange rate in effect as of September 30, 2024.

NON-QUALIFIED DEFERRED COMPENSATION

We have adopted the Executive Savings Investment Plan which provides for the deferral of compensation on a basis that is not tax-qualified.

Executive Savings Investment Plan

Under the terms of our ESIP, amounts that would be contributed, either by an executive or by our Company on the executive’s behalf, to our 401(k) plan but for tax limitations, are credited to the non-qualified ESIP. Under that plan, executives may elect to defer their contributions and Company contributions in any of the measurement fund options which track the performance of the Vanguard investment funds offered under our 401(k) plan. Deferrals and vested Company contributions may be transferred to different investment options at the executive’s discretion. Deferrals in the ESIP, adjusted for the net investment return, are paid out in a lump sum payment, or in five or ten annual installments, following retirement or other termination of employment.

NON-QUALIFIED DEFERRED COMPENSATION TABLE

Name	Plan	Executive Contributions in Fiscal 2024 ($) (1)			Edgewell Contributions in Fiscal 2024 ($) (2)			Aggregate Earnings in Fiscal 2024 ($) (3)			Aggregate Withdrawals/ Distributions ($)			Aggregate Balance at 9/30/2024 ($) (4)
Mr. Little	ESIP		$	141,372		$	149,846		$	352,509	$0				$	1,632,920
Mr. Little	Totals		$	141,372		$	149,846		$	352,509	$0				$	1,632,920
Mr. Sullivan	ESIP	$0			$0				$	41,880	$0				$	284,880
Mr. Sullivan	Totals	$0			$0				$	41,880	$0				$	284,880
Mr. O’Toole	ESIP		$	65,434		$	50,621		$	39,526	$0				$	293,109
Mr. O’Toole	Totals		$	65,994		$	50,621		$	39,526	$0				$	293,109
Ms. Langley	ESIP		$	87,230		$	30,738		$	45,092	$0				$	258,371
Ms. Langley	Totals		$	87,230		$	30,738		$	45,092	$0				$	258,371
Mr. Hill	ESIP		$	30,442		$	31,023		$	480,973	$0				$	2,774,178
	Deferred Compensation Plan	$0			$0				$	282,254		$	361,392		$	3,296,323
	Totals		$	30,442		$	31,023		$	763,227		$	361,392		$	6,070,501

(1)

Since 2012, our officers are no longer eligible to contribute to the deferred compensation plan. Mr. Hill is the only NEO who was a participant. The officer contributions to our ESIP during fiscal 2024 consist of deferrals of salary earned with respect to fiscal 2024.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

(2)

Our contributions to our ESIP consist of Company contributions which would have otherwise been contributed to the 401(k) plan but for limitations imposed by the U.S. Internal Revenue Service. These amounts, in their entirety, are included in the “All Other Compensation” column of the “Summary Compensation Table.”

(3)

Aggregate earnings/(losses) shown in this column consist of:

•

amounts credited to each executive under the investment options of each of the plans, reflecting actual earnings on investment funds offered under our 401(k) plan,

•

in the case of the prime rate option of our deferred compensation plan, the actual fund return rates,

•

the appreciation or depreciation in value of each of the investment options in the plans between October 1, 2023 and September 30, 2024, and

•

the appreciation or depreciation in value of vested restricted stock equivalents (see footnote 4 below).

The above-market portion of interest on the prime rate option (in excess of 120% of the APR) is set forth in the column titled “Change in Pension Value and Non-qualified Deferred Compensation Earnings” of the “Summary Compensation Table.”

(4)

The balances in that plan for each of the officers also include amounts deferred by them, Company matching deferrals, and earnings thereon, in years in which they were not named executive officers and their compensation was not included in the “Summary Compensation Table.” The balances also reflect earnings and losses during the past fiscal year.

		HUMAN CAPITAL & COMPENSATION COMMITTEE REPORT
		The HC&CC of our Board of Directors consists entirely of non-employee directors that are independent under the NYSE listing standards. The HC&CC has reviewed and discussed our Company’s Compensation Discussion and Analysis with management. Based on these reviews and discussions, the HC&CC recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement and in our Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2024.
					Respectfully submitted, Rakesh Sachdev, Chair Robert W. Black George Corbin Carla C. Hendra James C. Johnson Swan Sit Stephanie Stahl
		No portion of this HC&CC Report shall be deemed to be incorporated by reference into any filing under the Securities Act, the Exchange Act, or through any general statement incorporating by reference in its entirety the Proxy Statement in which this report appears, except to the extent that the Company specifically incorporates this report or a portion of it by reference. In addition, this report shall not be deemed to be filed under either the Securities Act or the Exchange Act. None of the members of HC&CC is or has been an officer or employee of our Company. None of our executive officers currently serves, or in the past year has served, as a member of the board of directors or compensation committee (or other board committees performing equivalent functions) of any entity that has one or more of its executive officers serving on our board of directors or HC&CC.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

We have not entered into general employment agreements with any of our named executive officers. However, equity awards under our A&R 2018 Plan and 2nd A&R 2018 Plan, and our deferred compensation plan provide for acceleration of vesting of certain awards in the event of certain terminations of employment. In September 2016, we instituted an Executive Severance Plan in which our NEOs and certain of our other key employees participate which provides benefits to participants in the event of an involuntary termination without cause or a voluntary termination as a result of good reason, as such terms are defined in the plan, including severance compensation, payment for accrued but unpaid paid time off and payments in respect of the monthly premium cost for group health plan benefits. Prior to April 25, 2019, we entered into change in control agreements with our NEOs and certain of our other key employees which provide severance compensation, acceleration of vesting and continuation of benefits upon qualified termination of employment following a change in control. Effective as of April 25, 2019, we have replaced the individual change in control agreements with a change in control plan (the “Change in Control Plan”).

The information below reflects the value of acceleration or incremental compensation which each officer would receive upon the termination of his or her employment or upon a change in control. Because the value of awards and incremental compensation depend on several factors, actual amounts can only be determined at the time of the event.

The information is based on the following assumptions:

•

the event of termination (death, permanent disability, involuntary termination or voluntary termination), or a change in control of our Company, occurred on September 30, 2024, the last day of our fiscal year;

•

the market value of our common stock on that date was $36.34 (the actual closing price on September 30, 2024, the last trading day of fiscal 2024);

•

each of the officers were terminated on that date; and

•

the individual federal tax rate was 37%, Connecticut state tax rate was 7% and FICA was 2.35%.

This information does not reflect benefits that are provided under our plans or arrangements that do not discriminate in favor of executive officers and are available generally to all salaried employees — such as amounts accrued under our savings investment plan, accumulated and vested benefits under our retirement plans (including our SERP and ESIP), health, welfare and disability benefits, and accrued vacation pay.

The information below also does not include amounts under our deferred compensation plan or ESIP that would be paid, or vested stock equivalents that would be issued, all as described in the “Non-qualified Deferred Compensation Table,” except to the extent that an officer is entitled to an accelerated benefit as a result of the termination. Any acceleration of equity awards would also include acceleration of dividends payable with respect to such awards, if any.

Death, Permanent Disability or Termination of Employment (Other Than Under the Executive Severance Plan or Upon a Change in Control)

Upon an officer’s death, permanent disability, involuntary termination, voluntary termination and, in some cases, retirement, the following long-term incentive awards may provide for acceleration of vesting. Awards are accelerated on a pro rata basis for retirement after attainment of age 55 with ten years of service if granted 12 or more months prior to retirement date. No awards are accelerated upon voluntary termination or involuntary termination.

Long-Term Incentive Award

Involuntary
Termination
or Voluntary
Termination

Death

Permanent
Disability

Retirement
After Age 55 with
10 years of Service

Three-year time-based restricted stock equivalent and stock options granted 11/12/2021, 11/11/2022 and 11/10/2023.

Forfeited

Accelerated

Pro Rata Vesting

Three-year performance-based restricted stock equivalent awards granted 11/12/2021, 11/11/2022 and 11/10/2023.

Forfeited

Accelerated

Pro Rata Vesting

The value of awards which would be accelerated for our NEOs upon death, permanent disability or retirement as of September 30, 2024 is shown in the following chart. The value of accelerated restricted stock equivalents reflects a stock price of $36.34 (the closing price of our common stock on September 30, 2024, the last trading day of the fiscal year). Stock market changes since October 1, 2024 are not reflected in these valuations.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

	Accelerated Restricted Stock Equivalents and Stock Option Awards
Name	Death			Permanent Disability			Retirement After Age 55 With 10 years of Service
Mr. Little		$	10,082,168		$	6,488,528		$	0
Mr. Sullivan		$	2,278,249		$	1,554,113		$	0
Mr. O’Toole		$	1,707,696		$	1,154,467		$	0
Ms. Langley		$	1,200,913		$	810,706		$	0
Mr. Hill	$0			$0				$	0

Upon termination of employment for any reason, vested account balances in our deferred compensation plan are paid out in cash to the participant in either a lump sum, or over a five or ten-year period, commencing six months from the date of termination.

In the event an officer’s employment is terminated due to permanent disability, our Company provides basic long-term disability benefits of 40% of the officer’s previous year’s salary and a one-time bonus up to $240,000. He or she may also be entitled to benefits under our optional long-term disability plan, which pays a supplemental benefit equal to a total of 662∕3% of the officer’s previous year’s salary and a one-time bonus up to $240,000. As noted in the “Summary Compensation Table,” our Company pays the premiums for $50,000 of term life and accidental death and dismemberment insurance for all U.S. employees, including the NEOs.

Executive Severance Plan

Our Executive Severance Plan provides benefits to a number of our Company’s executives, including the NEOs (each an “Eligible Employee”), in the event of a qualifying termination event (“Qualifying Termination”), which includes an involuntary termination without cause or a voluntary termination as a result of good reason. Under the plan:

•

“Cause” includes (i) the failure of an Eligible Employee to make a good faith effort to substantially perform their duties or an Eligible Employee’s insubordination with respect to a specific directive; (ii) an Eligible Employee’s dishonesty, negligence in the performance of his or her duties or engaging in willful misconduct, which in the case of any such negligence, has caused or is reasonably expected to result in direct or indirect material injury to our Company; (iii) breach by an Eligible Employee of any material provision of any written agreement with our Company or material violation of any Company policy; or (iv) an Eligible Employee’s commission of a crime that constitutes a felony or other crime of moral turpitude or fraud.

•

“Good reason” includes (i) a material diminution of an Eligible Employee’s base compensation or bonus opportunity; (ii) a material diminution of an Eligible Employee’s authority, duties, or responsibilities; or (iii) a change in the principal place of an Eligible Employee’s employment to a location that is more than 50 miles distant from the Eligible Employee’s then current principal place of employment.

Post-termination benefits for each NEO under the plan consist of a lump sum payment equal to:

•

1.5 times the officer’s annual base salary plus a severance bonus equal to the target short-term incentive plan bonus for the officer for the current fiscal year, except in the case of Mr. Little, where such payment will be equal to two times; and

•

1.5 times the monthly premium cost for group health plan benefits for the officer multiplied by 18, except in the case of Mr. Little, where the health costs will be multiplied by 24.

The payment of benefits under the plan is conditioned upon, among other things, the officer executing a general release in our Company’s favor, which shall include confidentiality, non-solicitation, non-disparagement and non-competition obligations of the officer.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Estimated Payments and Benefits

Based on the assumptions set out above, the following sets forth estimated payments to our NEOs upon a Qualifying Termination as of September 30, 2024 under the Executive Severance Plan:

Name	Severance Salary Payment			Severance Bonus Payment			Health & Welfare Benefits			Accrued Paid Time Off			Total
Mr. Little		$	2,200,000		$	2,750,000		$	73,008		$	0		$	5,023,008
Mr. Sullivan		$	1,200,000		$	900,000		$	59,293		$	0		$	2,159,293
Mr. O’Toole		$	975,000		$	731,250		$	50,143		$	0		$	1,756,393
Ms. Langley		$	750,000		$	525,000		$	72,650		$	0		$	1,347,650

Note: Mr. Hill is not included in this table due to his retirement on January 5, 2024. Please refer to footnote 6 of the “Summary Compensation Table” for further information.

Change in Control of Our Company

Effective April 25, 2019, we adopted a Change in Control Plan that covers our NEOs. All capitalized terms used below and not defined herein shall have the meanings set forth in the Change in Control Plan.

“Termination for cause” means a termination for willful breach of, or failure to perform, employment duties.

“Good reason” means, among other things, certain changes in the officer’s status or duties, failure to pay certain compensation or awards, relocation of his or her office, or improper termination.

A “Change in control” includes, among other things, acquisition of specified amounts of shares by any person, certain changes in the composition of our incumbent Board, approval of business combinations under certain circumstances, or other matters approved by our Board.

Upon a Participant’s Termination of Employment following a Change in Control, a Participant shall be entitled to the following benefits, provided that such Termination of Employment occurs during the Change in Control Period, and such Termination of Employment is not a result of a Participant’s Death, Retirement or Disability and (i) if by the Company, is not for Cause, or (ii) if by Participant, is for Good Reason:

•

Payment in full of Participant’s prorated bonus for the fiscal year in which the Termination of Employment occurs calculated as Participant’s Target Bonus for the fiscal year in which the Termination of Employment occurs, or, if greater, the actual bonus awarded to Participant under any short-term incentive plan(s) of our Company for the fiscal year immediately preceding the fiscal year in which the Termination occurs, divided by 365 and multiplied by the number of calendar days in said year immediately up to the day on which the Termination of Employment occurs, subject to any valid deferral election which was made prior to that time by the Participant under any Company qualified pension plan, non-qualified pension plan, 401(k) plan, excess 401(k) plan or non-qualified deferred compensation plan then in effect;

•

Accelerated vesting of all unvested stock options and restricted stock and stock equivalent awards, including performance awards, which have been granted or sold to the Participant by the Company and which have not otherwise vested;

•

Payment of a Participant’s base salary through Termination of Employment at the rate in effect at the time the Notice of Termination is given, plus all other amounts to which Participant is entitled under any compensation plan(s) or program(s) of our Company applicable to Participant at the time such payments are due under such plan(s) or program(s);

•

Additional pay calculated as the product of a predetermined amount applicable to Participant’s title multiplied by the sum of (x) the greater of (i) Participant’s annual base salary in effect immediately prior to the Termination of Employment, or (ii) Participant’s annual base salary in effect as of the date of the Change in Control, and (y) Participant’s Target Bonus Amount;

•

If not already vested, Participant shall be deemed fully vested as of the Termination of Employment in any Company retirement plan(s) or other written agreement(s) between Participant and our Company relating to pay or other retirement income benefits upon retirement in which Participant was a participant, party or beneficiary

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

immediately prior to the Change in Control, and any additional plan(s) or agreement(s) in which such Participant became a participant, party or beneficiary thereafter;

•

For the period of time after Termination of Employment applicable to Participant’s title, our Company shall continue health, vision, dental, life insurance and long-term disability benefits, including executive benefits, Participant and/or Participant’s family as if Participant’s employment with our Company had not been terminated as of the Termination of Employment, in accordance with our Company’s then-current plans, programs, practices and policies on terms and conditions (including the level of benefits, deductibles and employee payments for such benefits) not less favorable than those which are then being provided to peer executives of our Company;

•

If pursuant to the terms and conditions of any such health or welfare plan or program, our Company is not able to continue Participant’s and/or Participant’s family participation in the plan or program for all or any portion of such period applicable to Participant’s title, our Company will reimburse Participant for the cost of insurance for any such benefit for Participant and/or Participant’s family, for such period as such benefits are not able to be continued pursuant to a plan or program of our Company, less the amount that would have been paid by Participant for such benefits pursuant to our Company’s plan or program; and

•

Six months of outplacement services through a designated provider selected by our Company, terminating six months thereafter or upon the date Participant obtains other employment, whichever date is sooner.

The foregoing is subject to execution by Participant of a Release in favor of our Company no later than 60 days following such Participant’s Termination of Employment, including the Participant’s written acceptance of, and written agreement to comply with, the confidentiality, non-solicitation, non-disparagement and non-competition provisions set forth in the Release.

Estimated Payments and Benefits

Based on the assumptions set out above, the following chart sets forth estimated payments to our NEOs upon termination following a change in control. The value of accelerated restricted stock equivalents reflects a stock price of $36.34 (the closing price of our common stock on September 30, 2024, the last trading day of our fiscal year). Stock market declines and vesting and forfeitures of unvested restricted stock equivalents since October 1, 2024 are not reflected in these valuations.

	Accelerated or Additional Benefits – Termination following Change in Control
Name	Cash Severance			Retirement Benefits			Restricted Stock Equivalents, Three-Year Performance Awards, Stock Option Awards			Benefits			Excise Tax Reduction (1)			Total
Mr. Little		$	9,152,440		$	445,500		$	10,082,168		$	61,365		$	(378,296)		$	19,363,177
Mr. Sullivan		$	3,506,680		$	168,000		$	2,278,249		$	40,196	$0				$	5,993,125
Mr. O’Toole		$	2,840,344		$	136,500		$	1,707,696		$	29,418	$0				$	4,713,958
Ms. Langley		$	2,075,640		$	125,820		$	1,177,093		$	40,215		$	(460,613)		$	2,958,155

(1)

It was determined that a “golden parachute” excise tax would be due under the Code for Mr. Little and Ms. Langley and, therefore, we reduced the aggregate amount of the payments that would be payable to an amount such that no excise tax would be due.

Note: Mr. Hill is not included in this table due to his retirement on January 5, 2024.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Chief Executive Officer Pay Ratio Disclosure

As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K, we are providing the following information about the relationship of the median total compensation of our employees and the total compensation of our Chief Executive Officer, Mr. Little.

We selected September 30, 2024, the last day of our fiscal year, as the determination date for identifying the median employee and base salary as our consistently applied compensation measure (“CACM”). Using this CACM, we identified all employees whose base salary was estimated to be within a narrow range of the median. We selected an individual from this group as our median employee. The median employee selected has a total compensation of $47,458, calculated in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K. The total compensation of our Chief Executive Officer was $10,078,913. As a result, our estimate of the ratio of CEO pay to the median employee pay is 212 to 1.

The above pay ratio may not be comparable to the pay ratio disclosed by our peer companies due to differences in the geographic distribution of the workforce and nature of the work performed and differences in the methodology, reasonable estimates and assumptions we employed compared to different organizations.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

EQUITY COMPENSATION PLAN INFORMATION

The following table gives information about our Company’s common stock that may be issued upon the exercise of options, warrants and rights under all our Company’s existing compensation plans as of September 30, 2024:

Plan Category	(1) Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants and Rights		(2) Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights			(3) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (1), and as Noted Below)
Equity compensation plans approved by security holders		2,733,867		$	45.22		3,422,613
Equity compensation plans not approved by security holders		None			N/A		None
Total		2,733,867		$	45.22		3,422,613

(1)

The number of securities to be issued upon exercise of outstanding options, warrants and rights shown above, as of September 30, 2024, includes 1,588,251 restricted stock equivalents which have been granted under the terms of our Company’s 2000 Incentive Stock Plan, 2009 Incentive Stock Plan and 2018 Stock Incentive Plan, including all amendments, and 1,145,616 stock option awards which have been granted under the terms of the 2009 Incentive Stock Plan and 2018 Stock Incentive Plan, each as amended. No further awards may be made from the 2000 Incentive Stock Plan or 2009 Incentive Stock Plan.

(2)

The weighted average exercise price does not take into account securities which will be issued upon conversion of outstanding restricted stock equivalents.

(3)

This number only reflects securities available under the 2nd A&R 2018 Plan. Under the terms of that plan, any awards other than options, phantom stock options or stock appreciation rights are to be counted against the reserve available for issuance in a 1.95 to 1 ratio.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

PAY VERSUS PERFORMANCE

As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive “compensation actually paid” and certain company financial performance metrics. Compensation actually paid, as determined under SEC requirements, does not reflect the actual amount of compensation earned by or paid to our executive officers during a covered year. For further information concerning our pay-for-performance philosophy and how we align executive compensation with company financial performance, refer to the Compensation Discussion and Analysis.

Information presented in this section will not be deemed to be incorporated by reference into any of our filings under the Securities Act of 1933, as amended, or the Exchange Act, except as we may specifically do so.

Year (2)	Pay												Performance
	CEO						Average of Other NEOs						Cumulative Total Shareholder Return (Value of $100 Initial Investment) (1):						Net Income ($Mn)			Adjusted EBITDA (6) ($Mn)
	SCT Total Compensation			Compensation Actually Paid (3)			SCT Total Compensation			Compensation Actually Paid (4)			EPC			Peer Group (5)			Net Income ($Mn)			Adjusted EBITDA (6) ($Mn)
2024		$	10,078,914		$	6,817,054		$	2,466,073		$	1,802,417		$	138.78		$	132.51		$	98.6		$	353
2023		$	10,517,129		$	9,124,943		$	2,310,328		$	1,872,883		$	138.92		$	106.10		$	114.7		$	342
2022		$	9,320,280		$	10,600,848		$	1,900,947		$	2,402,210		$	138.52		$	91.47		$	99.5		$	335
2021		$	8,104,026		$	11,957,823		$	2,158,258		$	2,615,423		$	132.34		$	100.05		$	117.8		$	367

(1)

Represents the value of a hypothetical $100 investment beginning at market close on September 29, 2021, assuming reinvestment of dividends

(2)

The CEO for each covered year was Rod R. Little. The other NEOs for each covered year were as follows:

•

2024: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and LaTanya Langley

•

2023: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

•

2022: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

•

2021: Daniel J. Sullivan, Eric F. O’Toole, Marisa B. Iasenza and Anne-Sophie Gaget

(3)

Amounts reported in this column are based on total compensation reported for our CEO in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the table below. Fair value of equity awards was computed in accordance with the Company’s methodology used for financial reporting purposes.

	2024
Total Compensation for CEO as reported SCT for the covered year		$	10,078,914
Deduct pension values reported in SCT for the covered year		$	0
Deduct grant date fair value of equity awards reported in SCT for the covered year		$	(7,467,973)
Add pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year		$	0
Add fair values as of the end of the covered year of all equity awards granted during the covered year that are outstanding and unvested as of the end of such covered year		$	6,994,477
Add fair value as of the vesting date of any awards granted in the covered year that vested during the covered year		$	0
Add dividends paid on unvested shares/share units and stock options		$	201,256
Add the change in fair value (whether positive or negative) as of the end of the covered year of any equity awards granted in any prior year that are outstanding and unvested as of the end of such covered year		$	(2,377,963)
Add the change in fair value (whether positive or negative) as of the vesting date of any equity awards granted in any prior year for which all applicable vesting conditions were satisfied during the covered year		$	(611,657)
Subtract the fair value of any equity awards granted in a prior year that were forfeited in the covered year determined as of the end of the prior year		$	0
Compensation Actually Paid to CEO		$	6,817,054

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

(4)

Amounts reported in this column are based on average total compensation reported for our Other NEOs in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the table below. Fair value of equity awards was computed in accordance with the Company’s methodology used for financial reporting purposes.

	2024
Average Total Compensation for Other NEOs as reported SCT for the covered year		$	2,466,073
Deduct average pension values reported in SCT for the covered year		$	(59,708)
Deduct average grant date fair value of equity awards reported in SCT for the covered year		$	(966,555)
Add average pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year		$	0
Add average fair values as of the end of the covered year of all equity awards granted during the covered year that are outstanding and unvested as of the end of such covered year		$	916,070
Add average fair value as of the vesting date of any awards granted in the covered year that vested during the covered year		$	0
Add average dividends paid on unvested shares/share units and stock options		$	33,512
Add the average change in fair value (whether positive or negative) as of the end of the covered year of any equity awards granted in any prior year that are outstanding and unvested as of the end of such covered year		$	(259,699)
Add the average change in fair value (whether positive or negative) as of the vesting date of any equity awards granted in any prior year for which all applicable vesting conditions were satisfied during the covered year		$	(65,836)
Subtract the average fair value of any equity awards granted in a prior year that were forfeited in the covered year determined as of the end of the prior year		$	(261,441)
Average Compensation Actually Paid to Other NEOs		$	1,802,417

(5)

Pursuant to Item 402(v) of Regulation S-K, the Company used the same peer group used for purposes of Item 201€ of Regulation S-K, the S&P Composite 1500 Household Products Index.

(6)

Represent Adjusted EBITDA as shown in Appendix A.

Company’s Most Important Financial Performance Measures

The following were the most important financial performance measures used by the company to link executive compensation actually paid to the company’s NEOs for the most recently completed fiscal year to the company’s performance:

►

Total Shareholder Return (“TSR”)

►

Adjusted EBITDA

►

Net Income

Description of the Relationship Between Compensation Actually Paid to our Named Executive Officers and Company Performance

The charts below describe the relationship between compensation actually paid to our chief executive officer and to our other named executive officers (as calculated above) and our financial and stock performance for the indicated years. In addition, the first chart below compares our cumulative TSR and peer group cumulative TSR for the indicated years.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

STOCK OWNERSHIP INFORMATION

FIVE PERCENT OWNERS OF COMMON STOCK

The following table shows, reported as of November 29, 2024, the holdings of our Company’s common stock by any entity or person known to our Company to be the beneficial owner of more than 5% of the outstanding shares of our Company’s common stock.

Name and Address of Beneficial Owner	Amount and Nature of Beneficial Ownership		Percent of Class Outstanding (1)
BlackRock, Inc. 50 Hudson Yards, New York, NY 10001		8,194,607 (2)		16.3%
The Vanguard Group 100 Vanguard Blvd., Malvern, PA 19355		5,804,147 (3)		11.55%
Dimensional Fund Advisors LP 6300 Bee Cave Road, Bldg. 1, Austin, TX 78746		3,575,710 (4)		7.1%
American Century Companies, Inc. 4500 Main Street, Kansas City, MO 64111		3,506,682 (5)		7.11%

(1)

On November 29, 2024, there were 48,636,882 shares of our Company’s common stock outstanding.

(2)

As reported in a statement on Schedule 13G/A filed with the SEC on January 22, 2024, BlackRock, Inc. and related entities reported, as of December 31, 2023, sole voting power over 8,048,726 shares, and sole dispositive power over 8,194,607 shares.

(3)

As reported in a statement on Schedule 13G filed with the SEC on February 13, 2024, The Vanguard Group and related entities reported, as of December 29, 2023, shared voting power over 45,297 shares, sole dispositive power over 5,705,389 shares and shared dispositive power over 98,758 shares.

(4)

As reported in a statement on Schedule 13G filed with the SEC on February 9, 2024, Dimensional Fund Advisors LP (“DFA”) and related entities reported, as of December 29, 2023, sole voting power over 3,513,393 shares, and sole dispositive power over 3,575,710 shares. DFA, an investment advisor registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts (such investment companies, trusts and accounts, collectively referred to as the “Funds”). In certain cases, subsidiaries of DFA may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser and/or manager, DFA or its subsidiaries (collectively, “Dimensional”) may possess voting and/or investment power over the securities of the Issuer that are owned by the Funds and may be deemed to be the beneficial owner of the shares of the Issuer held by the Funds. However, all securities reported in this schedule are owned by the Funds. Dimensional disclaims beneficial ownership of such securities. In addition, the filing of this Schedule 13G shall not be construed as an admission that the reporting person or any of its affiliates is the beneficial owner of any securities covered by this 13G for any other purposes than Section 13(d) of the Securities Exchange Act of 1934.

(5)

As reported in a statement on Schedule 13G/A filed with the SEC on November 8, 2024, by American Century Companies, Inc., a parent holding company or control person; American Century Investment Management, Inc., an investment adviser; and Stowers Institute for Medical Research, a parent holding company or control person, reported, as of September 30, 2024, sole voting power over 3,382,558 shares, sole dispositive power over 3,506,682 shares. Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. (“ACIM”) serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

OWNERSHIP BY DIRECTORS AND EXECUTIVE OFFICERS

The table below contains information regarding beneficial common stock ownership by our directors, NEOs, and directors and executive officers as a group as of November 29, 2024. It does not reflect any changes in ownership that may have occurred after that date. In general, “beneficial ownership” includes those shares a director or executive officer has the power to vote or transfer, as well as shares owned by immediate family members that reside with the director or officer. Unless otherwise indicated, directors and executive officers named in the table below have sole voting and investment power with respect to the shares set forth in the table and none of the stock included in the table is pledged. The table also indicates shares that may be obtained within 60 days upon the exercise of options, or upon the conversion of unvested RSEs into shares of common stock.

Directors and
Executive Officers

Shares
Beneficially
Owned

% of Shares
Outstanding (1)
(*denotes less
than 1%)

Robert W. Black (2)

20,112

George R. Corbin (3)

20,112

Carla C. Hendra (4)

14,648

John C. Hunter, III (5)

47,181

James C. Johnson (6)

28,404

Joseph D. O’Leary (7)

20,432

Rakesh Sachdev (8)

24,323

Swan Sit (9)

15,499

Stephanie Stahl (10)

Gary K. Waring (11)

20,432

Rod R. Little (12)

719,256

1.5%

Daniel J. Sullivan (13)

177,007

Eric F. O’Toole (14)

74,292

LaTanya Langley (15)

25,925

John N. Hill (16)

164,231

All Executive Officers and Directors as a Group (18 persons)

1,459,246

3.0%

(1)

The number of shares outstanding for purposes of this calculation was the number outstanding as of November 29, 2024 plus the number of shares which could be acquired upon the exercise of vested options, or options that vest within 60 days of that date, by the applicable officer or director, the conversion of unvested RSEs as well as equivalents that vest within 60 days of that date and the number of stock equivalents held in the deferred compensation plan.

(2)

For Mr. Black: includes (i) 16,168 shares owned by Mr. Black; and (ii) 3,944 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs that will convert into shares of our common stock on February 5, 2025.

(3)

For Mr. Corbin: includes (i) 13,419 shares owned by Mr. Corbin; and (ii) 6,693 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

(4)

For Ms. Hendra: includes (i) 7,917 shares owned by Ms. Hendra; and (ii) 6,731 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

(5)

For Mr. Hunter: includes (i) 6,603 shares owned by Mr. Hunter; (ii) 22,709 vested RSEs deferred until retirement from our Board; and (iii) 17,869 units held in the Deferred Compensation Plan. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

(6)

For Mr. Johnson: includes (i) 2,000 shares owned by Mr. Johnson; (ii) 26,225 vested RSEs deferred until retirement from our Board; and (iii) 179 units held in the Deferred Compensation Plan. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

(7)

For Mr. O’Leary: includes (i) 17,276 shares owned by Mr. O’Leary; and (ii) 3,156 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs that will convert into shares of our common stock on February 5, 2025.

(8)

For Mr. Sachdev: includes 24,323 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

(9)

For Ms. Sit: includes 15,499 shares owned by Ms. Sit. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

(10)

For Ms. Stahl: has 2,773 and 1,340 unvested RSE awards which will be deferred when they vest on September 10, 2027 and February 5, 2025, respectively.

(11)

For Mr. Waring: includes (i) 2,677 shares owned by Mr. Waring; and (ii) 17,755 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs of which 60% will be deferred and 40% will convert into shares of our common stock when they vest on February 5, 2025.

(12)

For Mr. Little: includes (i) 310,513 shares owned by Mr. Little; and (ii) 408,743 vested but unexercised stock options. Does not include 93,654 unvested RSEs; 615,501 unvested PRSEs or 85,628 unvested stock options.

(13)

For Mr. Sullivan: includes (i) 90,418 shares owned by Mr. Sullivan; and (ii) 86,589 vested but unexercised stock options. Does not include 29,404 unvested RSEs; 129,231 unvested PRSEs; or 19,880 unvested stock options.

(14)

For Mr. O’Toole: includes (i) 32,391 shares owned by Mr. O’Toole; and (ii) 41,901 vested but unexercised stock options which he has 90 days from his departure on 11/15/2024 to exercise. Due to Mr. O’Toole’s departure, his unvested awards were forfeited.

(15)

For Ms. Langley: includes (i) 12,919 shares owned by Ms. Langley; and (ii) 13,006 vested but unexercised stock options. Does not include 17,373 unvested RSEs; 56,325 unvested PRSEs; or 12,437 unvested stock options.

(16)

For Mr. Hill: includes at the time of his retirement (i) 81,080 shares owned by Mr. Hill; and (ii) 83,151 vested stock options. Due to Mr. Hill’s retirement, all of his vested stock options expire on their original expiration date or five years from his retirement date of 1/5/2024, whichever is earliest. The data in this table represents information from his Exit Form 4. The Company does not have access to updated information as he is no longer required to report to the SEC.

Section 16(a) Beneficial Ownership Reporting Compliance

To the best of our knowledge, all filings of stock ownership and changes in stock ownership by our directors and executive officers and beneficial owners of more than 10% of our stock, which are required by rules of the SEC, were made on a timely basis in fiscal 2024.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

[Page Left Intentionally Blank]

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

ITEM 1. ELECTION OF DIRECTORS

Our Board currently consists of 10 members. All directors, except for Ms. Stahl, have been previously elected by our shareholders.

Ten directors will be elected at the Annual Meeting to serve for a one-year term expiring at our 2026 annual meeting of shareholders (“2026 Annual Meeting”). Our Board has nominated Messrs. Black, Corbin, Hunter, Johnson, Little, Sachdev and Waring and Mss. Hendra, Sit and Stahl for election as directors at this meeting. Each nominee is currently serving as a director and has consented to serve for the one-year term. Each nominee elected as a director will continue in office until his or her successor has been elected and qualified.

We do not know of any reason why any of the nominees for director named herein would be unable to serve; however, if any nominee is unable to serve as a director at the time of the Annual Meeting, your proxy may be voted for the election of another person our Board may nominate in his or her place, unless you indicate otherwise.

Vote Required. The affirmative vote of a majority of the voting power represented in person or by proxy and entitled to vote is required for the election of each director.

THE MEMBERS OF THE BOARD OF DIRECTORS
RECOMMEND A VOTE FOR THE ELECTION OF THE NOMINEES

Our Corporate Governance Principles require that any director-nominee who receives a number of votes cast in favor of their election that is less than a majority of the number of votes cast either for or against their election at a duly held meeting of the Company’s shareholders shall tender their resignation from the Board, which resignation shall be effective only upon its acceptance by the Board. In each such case, the Corporate Governance Committee will consider any such tendered resignation and, within a reasonable period of time, make a recommendation to the Board. The Corporate Governance Committee may consider any factors it deems relevant in deciding whether to recommend that the Board accept a director’s resignation. The Board will act following the receipt of the recommendation of the Corporate Governance Committee and will publicly disclose its decision. If the Board determines not to accept any such resignation, the Board will publicly disclose a detailed explanation of the rationale behind such decision within 60 days from the date such resignation is tendered. The policy is set forth within our Company’s Corporate Governance Principles, which is available on our website, www.edgewell.com, click on “Investors,” then “Corporate Governance,” then “Corporate Governance Principles.” Information on our website does not constitute a part of this Proxy Statement.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

[MISSING IMAGE: ph_ourcorporate-4clr.jpg]

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

ITEM 2. RATIFICATION OF APPOINTMENT OF THE INDEPENDENT AUDITOR

Our Audit Committee, in accordance with authority granted in its charter by our Board, appointed PricewaterhouseCoopers LLP as our Company’s independent auditor for fiscal 2024. PwC has served as our independent auditor since 1999, and PwC has begun certain work related to the fiscal 2025 audit as approved by our Audit Committee. Information on independent auditor fees for the last two fiscal years is set forth below. Our Board and the Audit Committee believe that the retention of PwC to serve as independent auditor is in the best interests of our Company and shareholders. In making this determination, our Board and the Audit Committee considered a number of factors, including:

•

Audit Committee members’ assessment of PwC’s performance;

•

Management’s assessment of PwC’s performance;

•

PwC’s independence and integrity;

•

PwC’s fees and the quality of services provided to Edgewell; and

•

PwC’s global capabilities and knowledge of our global operations.

Vote Required. The affirmative vote of a majority of the voting power represented in person or by proxy and entitled to vote is required for ratification.

THE MEMBERS OF THE AUDIT COMMITTEE AND THE BOARD OF DIRECTORS
RECOMMEND A VOTE FOR RATIFICATION OF THE APPOINTMENT OF
PWC AS OUR INDEPENDENT AUDITOR FOR FISCAL YEAR 2025

A representative of PwC will be present at the Annual Meeting and will have an opportunity to make a statement, if desired, as well as to respond to appropriate questions.

Although NYSE listing standards require that the Audit Committee be directly responsible for selecting and retaining the independent auditor, we are providing shareholders with the means to express their views on this matter. Although this vote will not be binding, in the event our shareholders fail to ratify the appointment of PwC, the Audit Committee will reconsider its appointment. Even if the appointment is ratified, the Audit Committee in its discretion may direct the appointment of a different independent auditing firm at any time during the year if the Audit Committee determines that such a change would be in the best interests of our Company and shareholders.

Audit Committee Pre-Approval Policy

The Audit Committee has a formal policy concerning approval of all services to be provided by our independent auditor, including audit, audit-related, tax and other services. The policy requires that all services the auditor may provide to us must be pre-approved by the Audit Committee. The chair of the Audit Committee has the authority to pre-approve permitted services that require action between regular committee meetings, provided he reports to the committee at the next regular meeting. Early in each fiscal year, the Audit Committee approves the list of planned audit and non-audit services to be provided by the auditor during that year, as well as a budget estimating spending for such services for the fiscal year. Any proposed services exceeding the maximum fee levels set forth in that budget must receive specific pre-approval by the Audit Committee. The Audit Committee approved all services provided by PwC during fiscal 2024 and fiscal 2023.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

[Page Left Intentionally Blank]

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

Services Provided by PricewaterhouseCoopers LLP

The following table discloses fees paid to PwC for the following professional services rendered during the last two fiscal years:

•

Audit Fees — These are fees for professional services performed by PwC for the audit of our annual financial statements and internal control over financial reporting, review of financial statements included in our 10-Q filings, and audit services that are normally provided in connection with statutory and regulatory filings or engagements.

•

Audit-Related Fees — These are fees for assurance and related services performed by PwC that are reasonably related to the performance of the audit or review of our financial statements. This includes: equity and debt offering related services; due diligence related to mergers and acquisitions; internal control reviews; attestations by PwC that are not required by statute or regulation; and consulting on financial accounting and reporting standards.

•

Tax Fees — These are fees for professional services performed by PwC with respect to tax compliance, tax advice and tax planning. This includes: preparation of original and amended tax returns for Edgewell and our consolidated subsidiaries; refund claims; payment planning; and tax audit assistance.

Fees Paid to PricewaterhouseCoopers LLP (in thousands)
Type	FY 2023			FY 2024
Audit Fees		$	2,706		$	2,759
Audit-Related Fees		$	8		$	20
Tax Fees		$	5		$	3
Total Fees		$	2,719		$	2,782

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

[MISSING IMAGE: ph_pricewaterhouse-4clr.jpg]

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

ITEM 3. ADVISORY VOTE ON EXECUTIVE COMPENSATION

As required by Section 14A of the Exchange Act, we are asking our shareholders to provide non-binding advisory approval of the compensation of our named executive officers, as disclosed pursuant to the compensation disclosure rules of the SEC. We encourage shareholders to review the “Compensation Discussion and Analysis” for details regarding our executive compensation programs. Our shareholder advisory vote on executive compensation was approved by 83.6% of our shareholders of the votes cast in favor of the advisory resolution at our 2024 Annual Meeting of Shareholders.

This vote is not intended to address any specific item of compensation, but rather the overall compensation of our NEOs and the philosophy, policies and practices that we use. We believe that our executive compensation program was designed appropriately and is working to ensure management’s interests are aligned with our shareholders’ interests. Our compensation programs are designed to enable and reinforce our Company’s overall business strategy by aligning pay with achievement of short and long term financial and strategic objectives, while providing a competitive level of compensation which is needed to recruit, retain and motivate talented executives critical to our success. For a more detailed discussion of our fiscal 2024 compensation program, see “Executive Compensation — Compensation Discussion and Analysis.”

In particular, during fiscal 2024, the HC&CC:

•

Established a short-term performance incentive plan for fiscal 2024 for the NEOs that provided an annual cash bonus based upon satisfaction of performance targets measured under multiple metrics:

•

Adjusted Net Sales growth to reward top-line growth and strong operating performance;

•

Adjusted EBITDA to encourage the executives to deliver bottom-line results; and

•

Strategic Priorities to promote a “one team mindset” by aligning the Company’s executive officers around a clear set of enterprise priorities and critical shared goals.

This short-term incentive program resulted in a combined weighted payout of 97% (see the section Short-Term Incentive Program — Annual Cash Bonus, Executive Officer Bonus Program for further information) of the target bonus amount for our executive officers based on outcomes under these performance metrics, reinforcing our pay-for-performance philosophy.

•

Approved long-term incentive plan grants of performance-based and time-based RSEs and stock options. The PRSEs are subject to satisfaction of relative TSR performance targets for the three fiscal year period ending with our Company’s 2026 fiscal year. With over two-thirds of the value of the long-term incentive awards consisting of PRSEs and stock options, the HC&CC believes it has emphasized our compensation principle of ‘alignment with shareholder interests,’ with our executives’ long-term incentive compensation tied directly to successful Company performance and creating value for shareholders.

Our Board believes our Company’s overall compensation program and practices support the Company’s compensation philosophy and business strategy. Accordingly, the Board recommends a vote FOR the adoption of the following advisory resolution, which will be presented at the Annual Meeting:

RESOLVED, that the shareholders of Edgewell approve, on a non-binding advisory basis, the compensation of the named executive officers, as disclosed pursuant to the compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and the accompanying footnotes and narratives.

Vote Required. The affirmative vote of a majority of the voting power represented in person or by proxy and entitled to vote is required for approval of the advisory vote on executive compensation.

THE MEMBERS OF THE BOARD OF DIRECTORS
RECOMMEND A VOTE FOR APPROVAL OF THE ADVISORY
VOTE ON EXECUTIVE COMPENSATION

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

PROXY STATEMENT — VOTING PROCEDURES & MEETING FAQS

YOUR VOTE IS VERY IMPORTANT

The Board is soliciting proxies to be used at the Annual Meeting. The Company will bear the cost of the solicitation of proxies by the Company. We have hired Alliance Advisors, LLC, a proxy solicitation firm, to assist us in soliciting proxies for a fee of $30,000 plus reasonable expenses. This Proxy Statement, the form of proxy and our 2024 Annual Report on Form 10-K will be available at www.proxyvote.com beginning on or about December 19, 2024. A Notice Regarding the Availability of Proxy Materials will be mailed to shareholders of record as of the Record Date, on or about December 19, 2024.

How to Receive Printed Materials

We have elected to take advantage of the SEC’s rule that allows us to furnish proxy materials to you online. We believe electronic delivery expedites shareholders’ receipt of materials, while lowering costs and reducing the environmental impact of our Annual Meeting by reducing printing and mailing of full sets of materials. On or about December 19, 2024, we will mail to many of our shareholders a Notice containing instructions on how to access our Proxy Statement and our 2024 Annual Report on Form 10-K online. If you receive a Notice by mail, you will not receive a printed copy of the proxy materials unless you specifically request one. The Notice contains instructions on how to receive a paper copy of the materials. In furtherance of our ongoing commitment to environmental stewardship, this year we have again partnered with the Arbor Day Foundation® so that for each shareholder who chooses to receive an e-version of our Proxy Statement, we’ll make a donation to plant one tree in a forest of great need.

Who Can Vote

Shareholders of Edgewell Personal Care Company (“Edgewell” or “Company”) common stock on November 29, 2024 may vote at the Annual Meeting and any adjournment or postponement thereof. On November 29, 2024, there were 48,726,166 shares of common stock outstanding. The shares of common stock held in our treasury will not be voted.

How You Can Vote

There are four voting methods for shareholders:

				Voting by MAIL. If you received a paper copy of the proxy materials, and if you choose to vote by mail, then complete a proxy card, date and sign it, and return it in the postage-paid envelope provided.
				Voting by TELEPHONE. You can vote your shares by telephone by calling 1-800-690-6903 and using the identification code indicated on the Notice Regarding the Availability of Proxy Materials or the proxy card mailed to you. Voting is available 24 hours a day, seven days a week.
				Voting by INTERNET. You can also vote via the Internet at www.proxyvote.com. Your identification code for Internet voting is on the Notice Regarding the Availability of Proxy Materials or the proxy card mailed to you, and voting is available 24 hours a day, seven days a week.
				Voting in PERSON at the Annual Meeting.

Votes submitted electronically over the Internet or by telephone must be received by 11:59 p.m. Eastern Time on February 5, 2025.

If your shares are held in the name of a bank, broker or other holder of record, you must obtain a proxy, executed in your favor, from the holder of record in order to vote such shares. Otherwise, you must follow the instructions given to you by such bank, broker or other holder of shares. See “Beneficial Owners and Broker Non-Votes” below.

If you vote by telephone or via the Internet, you should not return a proxy card.

Who Counts the Votes

Broadridge Financial Solutions, Inc. (“Broadridge”) has been engaged as our independent agent to tabulate shareholder votes. If you are a shareholder of record, and you choose to vote over the internet prior to the Annual Meeting or by telephone, Broadridge will access and tabulate your votes electronically, and if you have requested and

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

received proxy materials by mail or email and choose to sign and mail your proxy card, your executed proxy card will be returned directly to Broadridge for tabulation. If you hold your shares through a broker, your broker (or its agent for tabulating votes of shares held in “street name”) will return one proxy card to Broadridge on behalf of all its clients.

How You May Revoke or Change Your Vote

You can revoke your proxy at any time before it is voted at the Annual Meeting by:

•

sending written notice of revocation to our Corporate Secretary;

•

submitting another properly completed proxy by telephone, Internet or mail; or

•

attending the Annual Meeting and voting your shares by ballot.

General Information on Voting

You are entitled to cast one vote for each share of common stock you own on the Record Date. If you are a shareholder of record and you do not submit a proxy or vote in person, no votes will be cast on your behalf on any of the items of business at the Annual Meeting. The presence at the meeting, in person or by proxy, of the holders of a majority of the shares of our common stock entitled to vote at the Annual Meeting is necessary to constitute a quorum.

The election of each director nominee, the ratification of our independent registered public accounting firm for fiscal year 2025, and the approval of the executive compensation by non-binding vote, must be approved by a majority of the voting power represented at the Annual Meeting in person or by proxy and entitled to vote on the matter. Our Corporate Governance Principles require that any director-nominee who receives a number of votes cast in favor of their election that is less than a majority of the number of votes cast either for or against their election at a duly held meeting of the Company’s shareholders shall tender their resignation from the Board, which resignation shall be effective only upon its acceptance by the Board. In each such case, the Corporate Governance Committee will consider any such tendered resignation and, within a reasonable period of time, make a recommendation to the Board. The Corporate Governance Committee may consider any factors it deems relevant in deciding whether to recommend that the Board accept a director’s resignation. The Board will act following the receipt of the recommendation of the Corporate Governance Committee and will publicly disclose its decision. If the Board determines not to accept any such resignation, the Board will publicly disclose a detailed explanation of the rationale behind such decision within 60 days from the date such resignation is tendered. Shareholders do not have the right to vote cumulatively in electing directors. Shares represented by a proxy marked “against” or “abstain” on any matter will be considered present at the Annual Meeting for purposes of determining a quorum and for purposes of calculating the vote but will not be considered to have voted in favor of a director nominee. Therefore, any proxy marked “against” or “abstain” will have the effect of a vote against a nominee.

While the shareholder vote on executive compensation is advisory and not binding on our Company, our Board and the Human Capital & Compensation Committee of our Board, which is responsible for administering our executive compensation programs, are interested in the opinions expressed by our shareholders in their vote on these proposals and will consider the outcome of the votes when making future compensation decisions for our NEOs.

All shares for which proxies have been properly submitted — whether by telephone, Internet or mail — and not revoked, will be voted at the Annual Meeting in accordance with your instructions. If you sign a proxy card but do not give voting instructions, the shares represented by that proxy will be voted as recommended by our Board.

If any other matters are properly presented at the Annual Meeting for consideration, the persons named in your properly submitted proxy card will have the discretion to vote on those matters for you. As of the date of this Proxy Statement, no other matters have been raised for consideration at the Annual Meeting.

Beneficial Owners and Broker Non-Votes

If your shares are held by a bank, broker or other nominee, you are considered the “beneficial owner” of the shares, which are held in “street name.” If you hold your shares in street name, you can instruct the broker, bank or other nominee who is the shareholder of record how to vote these shares by using the voting instructions given to you by the broker, bank, or other nominee.

The broker, bank, or other nominee may vote the shares in the absence of your voting instructions only with regard to “routine” matters. The election of directors and the advisory vote on executive compensation are considered “non-routine” matters and, accordingly, if you do not instruct your broker, bank or other nominee how to vote in these matters, no votes will be cast on your behalf with respect to these matters.

Your broker, bank or other nominee does, however, have discretion to vote any uninstructed shares on the ratification of the appointment of our accounting firm. If the broker, bank or other nominee votes the uninstructed shares on the

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

ratification of the accounting firm (either personally or by proxy), these shares may be considered as “present” for quorum purposes but will not be deemed voted on other matters and will be considered “broker non-votes” with respect to such other matters.

Such broker non-votes shall have no effect on the votes on election of directors or the advisory vote on executive compensation.

ADDITIONAL INFORMATION

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Our Board has adopted a written policy regarding the review and approval or ratification of transactions involving our Company and our directors, nominees for directors, executive officers, immediate family members of these individuals, and shareholders owning 5% or more of our outstanding common stock, each of whom is referred to as a related party. The policy covers any related party transaction, arrangement or relationship where a related party has a direct or indirect material interest and the amount involved exceeds $120,000 in any calendar year. Under the policy, the Audit Committee of our Board is responsible for reviewing and approving, or ratifying, the material terms of any related party transactions.

The Audit Committee is charged with determining whether the terms of the transaction are any less favorable than those generally available from unaffiliated third parties and determining the extent of the related party’s interest in the transaction.

In adopting the policy, our Board reviewed certain types of related party transactions described below and determined that they should be deemed to be pre-approved, even if the aggregate amount involved might exceed $120,000:

•

officer or director compensation which would be required to be disclosed under Item 402 of the SEC’s compensation disclosure requirements, and expense reimbursements to these individuals in accordance with our policy;

•

transactions with another company at which a related party serves as an employee, director, or holder of less than 10% of that company’s outstanding stock, if the aggregate amount involved does not exceed the greater of $1 million or 2% of that company’s consolidated gross revenues;

•

charitable contributions to a charitable trust or organization for which a related party serves as an employee, officer or director, if the annual contributions by us do not exceed the greater of $1 million or 2% of the organization’s total annual receipts;

•

a Company director or an immediate family member, during any 12-month period within the last three years, received more than $120,000 in direct compensation from the Company, other than director and committee fees and pension or other forms of deferred compensation for prior service (provided such compensation is not contingent in any way on continued service); or

•

transactions in which all of our shareholders receive proportional benefits, the rates or charges involved are determined by competitive bids, the transaction involves obtaining services from a regulated entity at rates fixed by law, or the transaction involves bank services as a depositary of funds, transfer agent or registrar, or similar services.

Our legal department is primarily responsible for the development and implementation of processes and procedures to obtain information from our directors and executive officers with respect to related party transactions. During fiscal 2024, there were no transactions with executive officers, directors or their immediate family members which were in an amount in excess of $120,000, and in which any such person had a direct or indirect material interest.

OTHER BUSINESS

Our Board knows of no business which will be presented at the Annual Meeting other than that described above. Our bylaws provide that shareholders may nominate candidates for director or present a proposal or bring other business before an annual meeting only if they give timely written notice of the nomination or the matter to be brought not less than 90 days nor more than 120 days prior to the first anniversary of the prior year’s meeting, as described under “Shareholder Proposals for 2025 Annual Meeting.”

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

DELIVERY OF DOCUMENTS

Householding of Annual Meeting Materials. The SEC has approved a rule permitting the delivery of a single Notice Regarding the Availability of Proxy Materials and set of Proxy Statements and Annual Reports on Form 10-K (if paper copies of such documents have been delivered or requested), to any household at which two or more shareholders reside, unless we have received contrary instructions from one or more of the shareholders residing in such household. Each shareholder will continue to receive a separate proxy card. This procedure, referred to as “householding,” reduces the volume of duplicate information you receive, as well as our expenses. In order to take advantage of this opportunity, we will deliver only one copy of the Notice Regarding the Availability of Proxy Materials, and this Proxy Statement and related Annual Report on Form 10-K (if paper copies of such documents have been delivered or requested), to multiple shareholders who share an address, unless we receive contrary instructions from the impacted shareholders prior to the mailing date. If you prefer to receive separate copies of our Notice Regarding the Availability of Proxy Materials, our Proxy Statement or Annual Report on Form 10-K, either now or in the future, we will promptly deliver, upon your written or oral request submitted as set forth below, a separate copy of the Notice Regarding the Availability of Proxy Materials, Proxy Statement or Annual Report on Form 10-K, as applicable and as requested, to any shareholder at your address to which a single copy was delivered. If you and other shareholders in your household are currently receiving multiple copies of the Notice Regarding the Availability of Proxy Materials, and this Proxy Statement and our Annual Report on Form 10-K (if paper copies of such documents have been delivered or requested) and would like only one copy to be sent to your household, upon your written or oral request, we will discontinue delivering multiple copies of such document(s) to your household and only deliver one copy. Notice should be given to the Corporate Secretary, Edgewell Personal Care Company, 6 Research Drive, Shelton, Connecticut 06484, Telephone No. (203) 944-5500.

SHAREHOLDER PROPOSALS FOR 2026 ANNUAL MEETING

Any proposals to be presented at the 2026 Annual Meeting of Shareholders (“2026 Annual Meeting”), which is expected to be held on February 5, 2026, must be received by our Company, directed to the attention of our Corporate Secretary, no later than August 21, 2025 in order to be included in our Company’s Proxy Statement and form of proxy for that meeting under Rule 14a-8 of the Exchange Act. Upon receipt of any proposal, our Company will determine whether or not to include the proposal in the Proxy Statement and proxy card in accordance with regulations governing the solicitation of proxies. The proposal must comply in all respects with the rules and regulations of the SEC.

In order for a shareholder to nominate a candidate for director under our bylaws, timely notice of the nomination must be received by us in advance of the meeting. Ordinarily, such notice must be received not less than 90, nor more than 120, days before the first anniversary of the prior year’s meeting. For the 2026 Annual Meeting, the notice would have to be received between October 9, 2025 and November 8, 2025. However, in the event that (i) no annual meeting is held in 2025, or (ii) the date of the 2025 Annual Meeting is more than 30 days before or more than 60 days after the first anniversary of the Annual Meeting, notice must be received no earlier than the 120th day prior to the date of the 2025 Annual Meeting and not later than the close of business on the later of the 90th day prior to the date of the 2025 Annual Meeting, or the seventh day following the day on which notice of the date of the meeting was mailed or on which public notice of the meeting was given. The notice of nomination must include, as to each person whom the shareholder proposes to nominate for election, information required by our bylaws, including:

•

the nominee’s name, age, business and residential address;

•

the nominee’s principal occupation for the previous five years;

•

the nominee’s consent to being named as a nominee and to serving on our Board;

•

the nominee’s “disclosable interests” as of the date of the notice (which information shall be supplemented by such person, if any, not later than ten days after the record date of the 2025 Annual Meeting to disclose such ownership as of the record date), which includes:

•

shares of common stock; options, warrants, convertible securities, stock appreciation rights, or similar rights with respect to our common stock; any proxy, contract, arrangement, understanding, or relationship conveying a right to vote common stock;

•

any short interest with respect to our common stock;

•

any derivative instruments held by a partnership in which the nominee has a partnership interest;

•

rights to any performance-related fee based on any increase or decrease in the value of our common stock or any related derivative instrument; and

•

a description of all monetary or other material agreements, arrangements or understandings between the nominating shareholder and the nominee during the prior three years.

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

In addition, the nominating shareholder must provide their name and address and disclosable interests (as such term is described above). The shareholder must be present at the Annual Meeting of Shareholders at which the nomination is to be considered and must provide a completed questionnaire regarding the nominee’s background and qualification and compliance with our corporate governance, conflict of interest, and other pertinent policies and guidelines. To assist in the evaluation of shareholder-recommended candidates, the Corporate Governance Committee may request that the shareholder provide certain additional information required to be disclosed in our Company’s proxy statement under Regulation 14A of the Exchange Act.

In order for a shareholder to bring other business before a shareholder meeting, timely notice must be received by our Company during the same period as director nominations described above. Such notice must include a description of the proposed business and the reasons for the proposal, the name and address of the shareholder making the proposal, any financial or other interests of the shareholder in the proposal made, and the shareholder’s disclosable interests. These requirements are separate from the requirements a shareholder must meet to have a proposal included in our Company’s proxy statement.

Shareholders who intend to solicit proxies in reliance on the SEC’s universal proxy rule for director nominees submitted under the advance notice requirements of our Bylaws must comply with the additional requirements of Rule 14a-19(b). We encourage shareholders who wish to submit a proposal or nomination to seek independent counsel. In addition to satisfying the requirements under our Amended & Restated Bylaws, to comply with the universal proxy rules. Shareholders who intend to solicit proxies in support of director nominees other than our nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than December 3, 2025. Edgewell will not consider any proposal or nomination that is not timely or otherwise does not meet the Bylaws and SEC requirements. We reserve the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these and other applicable requirements.

In each case, the notice must be given to our Corporate Secretary, whose address is Edgewell Personal Care Company, 6 Research Drive, Shelton, Connecticut 06484. A copy of our Bylaws will be provided without charge upon written request to our Corporate Secretary.

				By Order of the Board of Directors,
				LaTanya Langley
	December 19, 2024			Chief People Officer & Chief Legal Officer and Corporate Secretary

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

APPENDIX A

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

In the “Proxy Statement Summary” and in the “Compensation Discussion and Analysis,” our Company presents certain non-GAAP financial information. These non-GAAP measures are referred to as “adjusted” or “organic” and exclude items which are considered by the Company as unusual or non-recurring, and which may have a disproportionate positive or negative impact on the Company’s financial results in any particular period. This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is a component in determining management’s incentive compensation. Finally, the Company believes this information provides a higher degree of transparency. The following provides additional detail on the Company’s non-GAAP measures.

The following tables present a reconciliation of Net Earnings to Adjusted EBITDA, a reconciliation of Net Sales to Adjusted Net Sales and a summary of key results for fiscal 2024.

The following provides additional detail on our Company’s non-GAAP measures.

•

Our Company analyzes our net sales on an organic basis to better measure the comparability of results between periods. Organic net sales exclude the impact of changes in foreign currency. This information is provided because these fluctuations can distort the underlying change in net sales either positively or negatively.

•

Adjusted EBITDA is defined as earnings before income taxes, interest expense, net, depreciation and amortization and excludes items which are considered by our Company as unusual or non-recurring, and which may have a disproportionate positive or negative impact on our Company’s financial results in any particular period.

•

Additionally, we utilize “adjusted” non-GAAP measures, including adjusted gross margin, adjusted selling general and administrative (“SG&A”), adjusted operating income, adjusted effective tax rate, adjusted net earnings, and adjusted diluted net earnings per share internally to make operating decisions.

The following table provides a reconciliation of net sales to adjusted net sales for fiscal 2024.

Net Sales — Total Company

	For the Year Ended September 30, 2024
Net sales		$	2,253.7
Impact of currency versus plan			(12.5)
Adjusted Net Sales		$	2,241.2

Edgewell | 2024 Proxy Statement

A-1

TABLE OF CONTENTS

The Company reports financial results on a GAAP and adjusted basis. The table below is used to reconcile Net earnings to EBITDA and Adjusted EBITDA, which are non-GAAP measures, to improve comparability of results between periods.

	For year ended September 30, 2024
Net earnings		$	98.6
Income tax provision			22.3
Interest expense, net			73.1
Depreciation and amortization			88.0
EBITDA		$	282.0
Restructuring and repositioning expenses			36.0
Acquisition and integration planning costs			6.1
Sun Care reformulation			4.4
Wet Ones manufacturing plant fire			12.2
Legal matters			3.9
Loss on investment			3.1
Other project costs			5.3
Adjusted EBITDA		$	353.0

The following is a summary of key results for fiscal 2024. Net earnings and diluted earnings per share (“EPS”) were impacted by certain costs or income, as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are non-GAAP measures.

	Year Ended September 30, 2024
	Gross Profit			SG&A			Operating Income			EBIT			Income Taxes			Net Earnings			Diluted EPS
GAAP – Reported		$	955.7		$	430.1		$	199.3		$	120.9		$	22.3		$	98.6		$	1.97
Restructuring and repositioning expenses			—			0.1			36.0			36.0			8.8			27.2			0.54
Acquisition and integration costs			3.3			2.8			6.1			6.1			1.5			4.6			0.09
Sun Care reformulation			—			—			4.4			4.4			1.1			3.3			0.07
Wet Ones manufacturing plant fire			12.2			—			12.2			12.2			3.0			9.2			0.18
Legal matters			—			3.9			3.9			3.9			1.0			2.9			0.06
Loss on investment			—			—			—			3.1			—			3.1			0.06
Other project costs			—			5.3			5.3			5.3			1.2			4.1			0.08
Total Adjusted Non-GAAP		$	971.2		$	418.0		$	267.2		$	191.9		$	38.9		$	153.0		$	3.05
GAAP as a percent of net sales			42.4%			19.1%			8.8%	GAAP effective tax rate								18.5%
Adjusted as a percent of net sales			43.1%			18.5%			11.9%	Adjusted effective tax rate								20.3%

A-2

Edgewell | 2024 Proxy Statement

TABLE OF CONTENTS

TABLE OF CONTENTS

[MISSING IMAGE: px_24edgewellpy01pg01-bw.jpg]

EDGEWELL PERSONAL CARE COMPANY 6 RESEARCH DRIVE SHELTON, CT 06484 SCAN TO VIEW MATERIALS & VOTE VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on February 5, 2025. Follow the instructions to obtain your records and to create an electronic voting instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time on February 5, 2025. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. GO GREEN! We'll plant a tree for every shareholder who switches to e-delivery of proxy materials. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: V59804-P21460 KEEP THIS PORTION FOR YOUR RECORDS EDGEWELL PERSONAL CARE COMPANY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" ITEMS 1, 2 AND 3: 1. Election of Directors Nominees: For Against Abstain 1a. 1b. 1c. Robert W. Black George R. Corbin Carla C. Hendra !!!!!!!!!2. To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2025. 3. To cast a non-binding advisory vote on executive compensation. For !!Against !!Abstain !!1d. John C. Hunter, III !!!NOTE: Such other business as may properly come before the meeting or any adjournment thereof. 1e. James C. Johnson !!!1f. Rod R. Little !!!1g. Rakesh Sachdev !!!1h. Swan Sit !!!1i. Stephanie Stahl !!!Yes No 1j. Gary K. Waring !!!Please indicate if you plan to attend the meeting. !!Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date

TABLE OF CONTENTS

[MISSING IMAGE: px_24edgewellpy01pg02-bw.jpg]

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Annual Report on Form 10-K are available at www.proxyvote.com. V59805-P21460 EDGEWELL PERSONAL CARE COMPANY Annual Meeting of Shareholders February 6, 2025, 8:30 AM, Eastern Time This proxy is solicited by the Board of Directors The shareholder(s) hereby appoint(s) Rod R. Little and LaTanya Langley, or either of them, as proxies, each with the power to appoint his/her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of EDGEWELL PERSONAL CARE COMPANY that the shareholder(s) is/are entitled to vote at the Annual Meeting of Shareholders to be held at 8:30 AM, Eastern Time on February 6, 2025, at the Renaissance Daytona Beach Oceanfront Hotel, 640 North Atlantic Avenue, Daytona Beach, Florida, and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors' recommendations. Continued and to be signed on reverse side

DEF 14A false 0001096752 0001096752 2023-10-01 2024-09-30 0001096752 2022-10-01 2023-09-30 0001096752 2021-10-01 2022-09-30 0001096752 2020-10-01 2021-09-30 0001096752 epc:PensionValueInCompensationTableForTheApplicableYearMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsValueInCompensationTableForTheApplicableYearMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:PensionAdjustmentsServiceCostMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:FairValueOfAnyEquityAwardsGrantedInAPriorYearThatWereForfeitedInTheCoveredYearDeterminedAsOfTheEndOfThePriorYearMember ecd:PeoMember 2023-10-01 2024-09-30 0001096752 epc:PensionValueInCompensationTableForTheApplicableYearMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsValueInCompensationTableForTheApplicableYearMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:PensionAdjustmentsServiceCostMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 epc:FairValueOfAnyEquityAwardsGrantedInAPriorYearThatWereForfeitedInTheCoveredYearDeterminedAsOfTheEndOfThePriorYearMember ecd:NonPeoNeoMember 2023-10-01 2024-09-30 0001096752 2 2023-10-01 2024-09-30 0001096752 1 2023-10-01 2024-09-30 0001096752 3 2023-10-01 2024-09-30 iso4217:USD

Cover	12 Months Ended
Cover	Sep. 30, 2024
Document Information [Line Items]
Document Type	DEF 14A
Amendment Flag	false
Entity Information [Line Items]
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Central Index Key	0001096752

Pay vs Performance Disclosure - USD ($)

12 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2021

Pay vs Performance Disclosure

Pay vs Performance Disclosure, Table

Year (2)	Pay												Performance
	CEO						Average of Other NEOs						Cumulative Total Shareholder Return (Value of $100 Initial Investment) (1):						Net Income ($Mn)			Adjusted EBITDA (6) ($Mn)
	SCT Total Compensation			Compensation Actually Paid (3)			SCT Total Compensation			Compensation Actually Paid (4)			EPC			Peer Group (5)			Net Income ($Mn)			Adjusted EBITDA (6) ($Mn)
2024		$	10,078,914		$	6,817,054		$	2,466,073		$	1,802,417		$	138.78		$	132.51		$	98.6		$	353
2023		$	10,517,129		$	9,124,943		$	2,310,328		$	1,872,883		$	138.92		$	106.10		$	114.7		$	342
2022		$	9,320,280		$	10,600,848		$	1,900,947		$	2,402,210		$	138.52		$	91.47		$	99.5		$	335
2021		$	8,104,026		$	11,957,823		$	2,158,258		$	2,615,423		$	132.34		$	100.05		$	117.8		$	367

(1)

Represents the value of a hypothetical $100 investment beginning at market close on September 29, 2021, assuming reinvestment of dividends

(2)

The CEO for each covered year was Rod R. Little. The other NEOs for each covered year were as follows:

•

2024: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and LaTanya Langley

•

2023: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

•

2022: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

•

2021: Daniel J. Sullivan, Eric F. O’Toole, Marisa B. Iasenza and Anne-Sophie Gaget

(3)

	2024
Total Compensation for CEO as reported SCT for the covered year		$	10,078,914
Deduct pension values reported in SCT for the covered year		$	0
Deduct grant date fair value of equity awards reported in SCT for the covered year		$	(7,467,973)
Add pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year		$	0
Add fair values as of the end of the covered year of all equity awards granted during the covered year that are outstanding and unvested as of the end of such covered year		$	6,994,477
Add fair value as of the vesting date of any awards granted in the covered year that vested during the covered year		$	0
Add dividends paid on unvested shares/share units and stock options		$	201,256
Add the change in fair value (whether positive or negative) as of the end of the covered year of any equity awards granted in any prior year that are outstanding and unvested as of the end of such covered year		$	(2,377,963)
Add the change in fair value (whether positive or negative) as of the vesting date of any equity awards granted in any prior year for which all applicable vesting conditions were satisfied during the covered year		$	(611,657)
Subtract the fair value of any equity awards granted in a prior year that were forfeited in the covered year determined as of the end of the prior year		$	0
Compensation Actually Paid to CEO		$	6,817,054

(4)

	2024
Average Total Compensation for Other NEOs as reported SCT for the covered year		$	2,466,073
Deduct average pension values reported in SCT for the covered year		$	(59,708)
Deduct average grant date fair value of equity awards reported in SCT for the covered year		$	(966,555)
Add average pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year		$	0
Add average fair values as of the end of the covered year of all equity awards granted during the covered year that are outstanding and unvested as of the end of such covered year		$	916,070
Add average fair value as of the vesting date of any awards granted in the covered year that vested during the covered year		$	0
Add average dividends paid on unvested shares/share units and stock options		$	33,512
Add the average change in fair value (whether positive or negative) as of the end of the covered year of any equity awards granted in any prior year that are outstanding and unvested as of the end of such covered year		$	(259,699)
Add the average change in fair value (whether positive or negative) as of the vesting date of any equity awards granted in any prior year for which all applicable vesting conditions were satisfied during the covered year		$	(65,836)
Subtract the average fair value of any equity awards granted in a prior year that were forfeited in the covered year determined as of the end of the prior year		$	(261,441)
Average Compensation Actually Paid to Other NEOs		$	1,802,417

(5)

Pursuant to Item 402(v) of Regulation S-K, the Company used the same peer group used for purposes of Item 201€ of Regulation S-K, the S&P Composite 1500 Household Products Index.

(6)

Represent Adjusted EBITDA as shown in Appendix A.

Company Selected Measure Name

AdjustedEBITDA

Named Executive Officers, Footnote

(2)

The CEO for each covered year was Rod R. Little. The other NEOs for each covered year were as follows:

•

2024: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and LaTanya Langley

•

2023: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

•

2022: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

•

2021: Daniel J. Sullivan, Eric F. O’Toole, Marisa B. Iasenza and Anne-Sophie Gaget

Peer Group Issuers, Footnote

(5)

Pursuant to Item 402(v) of Regulation S-K, the Company used the same peer group used for purposes of Item 201€ of Regulation S-K, the S&P Composite 1500 Household Products Index.

PEO Total Compensation Amount

$ 10,078,914

$ 10,517,129

$ 9,320,280

$ 8,104,026

PEO Actually Paid Compensation Amount

$ 6,817,054

9,124,943

10,600,848

11,957,823

Adjustment To PEO Compensation, Footnote

(3)

	2024
Total Compensation for CEO as reported SCT for the covered year		$	10,078,914
Deduct pension values reported in SCT for the covered year		$	0
Deduct grant date fair value of equity awards reported in SCT for the covered year		$	(7,467,973)
Add pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year		$	0
Add fair values as of the end of the covered year of all equity awards granted during the covered year that are outstanding and unvested as of the end of such covered year		$	6,994,477
Add fair value as of the vesting date of any awards granted in the covered year that vested during the covered year		$	0
Add dividends paid on unvested shares/share units and stock options		$	201,256
Add the change in fair value (whether positive or negative) as of the end of the covered year of any equity awards granted in any prior year that are outstanding and unvested as of the end of such covered year		$	(2,377,963)
Add the change in fair value (whether positive or negative) as of the vesting date of any equity awards granted in any prior year for which all applicable vesting conditions were satisfied during the covered year		$	(611,657)
Subtract the fair value of any equity awards granted in a prior year that were forfeited in the covered year determined as of the end of the prior year		$	0
Compensation Actually Paid to CEO		$	6,817,054

Non-PEO NEO Average Total Compensation Amount

$ 2,466,073

2,310,328

1,900,947

2,158,258

Non-PEO NEO Average Compensation Actually Paid Amount

$ 1,802,417

1,872,883

2,402,210

2,615,423

Adjustment to Non-PEO NEO Compensation Footnote

(4)

	2024
Average Total Compensation for Other NEOs as reported SCT for the covered year		$	2,466,073
Deduct average pension values reported in SCT for the covered year		$	(59,708)
Deduct average grant date fair value of equity awards reported in SCT for the covered year		$	(966,555)
Add average pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year		$	0
Add average fair values as of the end of the covered year of all equity awards granted during the covered year that are outstanding and unvested as of the end of such covered year		$	916,070
Add average fair value as of the vesting date of any awards granted in the covered year that vested during the covered year		$	0
Add average dividends paid on unvested shares/share units and stock options		$	33,512
Add the average change in fair value (whether positive or negative) as of the end of the covered year of any equity awards granted in any prior year that are outstanding and unvested as of the end of such covered year		$	(259,699)
Add the average change in fair value (whether positive or negative) as of the vesting date of any equity awards granted in any prior year for which all applicable vesting conditions were satisfied during the covered year		$	(65,836)
Subtract the average fair value of any equity awards granted in a prior year that were forfeited in the covered year determined as of the end of the prior year		$	(261,441)
Average Compensation Actually Paid to Other NEOs		$	1,802,417